Psychostimulants as Cognitive Enhancers: The Prefrontal Cortex, Catecholamines, and Attention-Deficit/Hyperactivity Disorder
Psychostimulants exert behavioral-calming and cognition-enhancing actions in the treatment of attention-deficit/hyperactivity disorder (ADHD). Contrary to early views, extensive research demonstrates that these actions are not unique to ADHD. Specifically, when administered at low and clinically rel...
Saved in:
| Published in | Biological psychiatry (1969) Vol. 69; no. 12; pp. e101 - e111 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
15.06.2011
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Psychostimulants exert behavioral-calming and cognition-enhancing actions in the treatment of attention-deficit/hyperactivity disorder (ADHD). Contrary to early views, extensive research demonstrates that these actions are not unique to ADHD. Specifically, when administered at low and clinically relevant doses, psychostimulants improve a variety of behavioral and cognitive processes dependent on the prefrontal cortex (PFC) in subjects with and without ADHD. Despite the longstanding clinical use of these drugs, the neural mechanisms underlying their cognition-enhancing/therapeutic actions have only recently begun to be examined. At behaviorally activating doses, psychostimulants produce large and widespread increases in extracellular levels of brain catecholamines. In contrast, cognition-enhancing doses of psychostimulants exert regionally restricted actions, elevating extracellular catecholamine levels and enhancing neuronal signal processing preferentially within the PFC. Additional evidence suggests a prominent role of PFC α
2 and D1 receptors in the behavioral and electrophysiological actions of low-dose psychostimulants. These and other observations indicate a pivotal role of PFC catecholamines in the cognition-enhancing and therapeutic actions of psychostimulants, as well as other drugs used in the treatment of ADHD. This information may be particularly relevant for the development of novel pharmacological treatments for ADHD and other conditions associated with PFC dysregulation. |
|---|---|
| AbstractList | Psychostimulants exert behavioral-calming and cognition-enhancing actions in the treatment of attention-deficit/hyperactivity disorder (ADHD). Contrary to early views, extensive research demonstrates that these actions are not unique to ADHD. Specifically, when administered at low and clinically relevant doses, psychostimulants improve a variety of behavioral and cognitive processes dependent on the prefrontal cortex (PFC) in subjects with and without ADHD. Despite the longstanding clinical use of these drugs, the neural mechanisms underlying their cognition-enhancing/therapeutic actions have only recently begun to be examined. At behaviorally activating doses, psychostimulants produce large and widespread increases in extracellular levels of brain catecholamines. In contrast, cognition-enhancing doses of psychostimulants exert regionally restricted actions, elevating extracellular catecholamine levels and enhancing neuronal signal processing preferentially within the PFC. Additional evidence suggests a prominent role of PFC α2 and D1 receptors in the behavioral and electrophysiological actions of low-dose psychostimulants. These and other observations indicate a pivotal role of PFC catecholamines in the cognition-enhancing and therapeutic actions of psychostimulants, as well as other drugs used in the treatment of ADHD. This information may be particularly relevant for the development of novel pharmacological treatments for ADHD and other conditions associated with PFC dysregulation. Psychostimulants exert behavioral-calming and cognition-enhancing actions in the treatment of attention-deficit/hyperactivity disorder (ADHD). Contrary to early views, extensive research demonstrates that these actions are not unique to ADHD. Specifically, when administered at low and clinically relevant doses, psychostimulants improve a variety of behavioral and cognitive processes dependent on the prefrontal cortex (PFC) in subjects with and without ADHD. Despite the longstanding clinical use of these drugs, the neural mechanisms underlying their cognition-enhancing/therapeutic actions have only recently begun to be examined. At behaviorally activating doses, psychostimulants produce large and widespread increases in extracellular levels of brain catecholamines. In contrast, cognition-enhancing doses of psychostimulants exert regionally restricted actions, elevating extracellular catecholamine levels and enhancing neuronal signal processing preferentially within the PFC. Additional evidence suggests a prominent role of PFC α(2) and D1 receptors in the behavioral and electrophysiological actions of low-dose psychostimulants. These and other observations indicate a pivotal role of PFC catecholamines in the cognition-enhancing and therapeutic actions of psychostimulants, as well as other drugs used in the treatment of ADHD. This information may be particularly relevant for the development of novel pharmacological treatments for ADHD and other conditions associated with PFC dysregulation.Psychostimulants exert behavioral-calming and cognition-enhancing actions in the treatment of attention-deficit/hyperactivity disorder (ADHD). Contrary to early views, extensive research demonstrates that these actions are not unique to ADHD. Specifically, when administered at low and clinically relevant doses, psychostimulants improve a variety of behavioral and cognitive processes dependent on the prefrontal cortex (PFC) in subjects with and without ADHD. Despite the longstanding clinical use of these drugs, the neural mechanisms underlying their cognition-enhancing/therapeutic actions have only recently begun to be examined. At behaviorally activating doses, psychostimulants produce large and widespread increases in extracellular levels of brain catecholamines. In contrast, cognition-enhancing doses of psychostimulants exert regionally restricted actions, elevating extracellular catecholamine levels and enhancing neuronal signal processing preferentially within the PFC. Additional evidence suggests a prominent role of PFC α(2) and D1 receptors in the behavioral and electrophysiological actions of low-dose psychostimulants. These and other observations indicate a pivotal role of PFC catecholamines in the cognition-enhancing and therapeutic actions of psychostimulants, as well as other drugs used in the treatment of ADHD. This information may be particularly relevant for the development of novel pharmacological treatments for ADHD and other conditions associated with PFC dysregulation. Psychostimulants exert behavioral-calming and cognition-enhancing actions in the treatment of attention-deficit/hyperactivity disorder (ADHD). Contrary to early views, extensive research demonstrates that these actions are not unique to ADHD. Specifically, when administered at low and clinically relevant doses, psychostimulants improve a variety of behavioral and cognitive processes dependent on the prefrontal cortex (PFC) in subjects with and without ADHD. Despite the longstanding clinical use of these drugs, the neural mechanisms underlying their cognition-enhancing/therapeutic actions have only recently begun to be examined. At behaviorally activating doses, psychostimulants produce large and widespread increases in extracellular levels of brain catecholamines. In contrast, cognition-enhancing doses of psychostimulants exert regionally restricted actions, elevating extracellular catecholamine levels and enhancing neuronal signal processing preferentially within the PFC. Additional evidence suggests a prominent role of PFC α 2 and D1 receptors in the behavioral and electrophysiological actions of low-dose psychostimulants. These and other observations indicate a pivotal role of PFC catecholamines in the cognition-enhancing and therapeutic actions of psychostimulants, as well as other drugs used in the treatment of ADHD. This information may be particularly relevant for the development of novel pharmacological treatments for ADHD and other conditions associated with PFC dysregulation. Psychostimulants exert behavioral-calming and cognition-enhancing actions in the treatment of attention deficit hyperactivity disorder (ADHD). Contrary to early views, extensive research demonstrates that these actions are not unique to ADHD. Specifically, when administered at low and clinically-relevant doses, psychostimulants improve a variety of behavioral and cognitive processes dependent on the prefrontal cortex (PFC) in subjects with and without ADHD. Despite the longstanding clinical use of these drugs, the neural mechanisms underlying their cognition-enhancing/therapeutic actions have only recently begun to be examined. At behaviorally-activating doses, psychostimulants produce large and widespread increases in extracellular levels of brain catecholamines. In contrast, cognition-enhancing doses of psychostimulants exert regionally-restricted actions, elevating extracellular catecholamine levels and enhancing neuronal signal processing preferentially within the PFC. Additional evidence suggests a prominent role of PFC α 2 - and D1 receptors in the behavioral and electrophysiological actions of low-dose psychostimulants. These and other observations indicate a pivotal role of PFC catecholamines in the cognition-enhancing and therapeutic actions of psychostimulants as well as other drugs used in the treatment of ADHD. This information may be particularly relevant for the development of novel pharmacological treatments for ADHD and other conditions associated with PFC dysregulation. Psychostimulants exert behavioral-calming and cognition-enhancing actions in the treatment of attention-deficit/hyperactivity disorder (ADHD). Contrary to early views, extensive research demonstrates that these actions are not unique to ADHD. Specifically, when administered at low and clinically relevant doses, psychostimulants improve a variety of behavioral and cognitive processes dependent on the prefrontal cortex (PFC) in subjects with and without ADHD. Despite the longstanding clinical use of these drugs, the neural mechanisms underlying their cognition-enhancing/therapeutic actions have only recently begun to be examined. At behaviorally activating doses, psychostimulants produce large and widespread increases in extracellular levels of brain catecholamines. In contrast, cognition-enhancing doses of psychostimulants exert regionally restricted actions, elevating extracellular catecholamine levels and enhancing neuronal signal processing preferentially within the PFC. Additional evidence suggests a prominent role of PFC α(2) and D1 receptors in the behavioral and electrophysiological actions of low-dose psychostimulants. These and other observations indicate a pivotal role of PFC catecholamines in the cognition-enhancing and therapeutic actions of psychostimulants, as well as other drugs used in the treatment of ADHD. This information may be particularly relevant for the development of novel pharmacological treatments for ADHD and other conditions associated with PFC dysregulation. |
| Author | Devilbiss, David M. Berridge, Craig W. |
| Author_xml | – sequence: 1 givenname: Craig W. surname: Berridge fullname: Berridge, Craig W. email: berridge@wisc.edu – sequence: 2 givenname: David M. surname: Devilbiss fullname: Devilbiss, David M. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20875636$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkk9vEzEQxS1URNPCV6j2xqWb2t5d20GookoLRapEJcrZcryzzYSNndpORCQ-PF6lQdAD5eR_M783es9H5MB5B4ScMDpmlImzxXiGfhW3dj7mNF9SMaa8ekFGTMmq5DXlB2REKRVlxXl1SI5iXOSj5Jy9IoecKtmISozIz9uB4WPC5bo3LsXCxGLq7x0m3EBx5ebGWQjxXXE3h-I2QBe8S6bPNSHBj9NiahJkQG-W6CCeFsa1xUVK4BJ6V15ChxbT2fV2BcHYzMS0LS4x-tBCeE1edqaP8OZxPSbfPl7dTa_Lmy-fPk8vbkrbTFQqFahGNjCroDNd103qlqtK1aKWBgD4ZEY7RSU1YiLbjho2U0yJrqWihbY2ta2OyfmOu1rPltDaPFwwvV4FXJqw1d6g_vvF4Vzf-42uKOOyFhnw9hEQ_MMaYtJLjBb67Bj4ddRK0qaW2d5cefKn1G-NveO54P2uwAYfY_ZTZ3_MYFZWxl4zqoeA9ULvA9ZDwJoKnQPO7eJJ-17h2cYPu0bIRm8Qgo4WIWfbYgCbdOvxecT5E4Tt0aE1_XfYQlz4dXA5Rs105Jrqr8P3G34fGzZSNf8G_M8EvwD7e_LI |
| CitedBy_id | crossref_primary_10_1371_journal_pone_0239257 crossref_primary_10_1016_j_brainres_2024_149040 crossref_primary_10_1080_1028415X_2019_1684688 crossref_primary_10_1016_j_braindev_2014_03_011 crossref_primary_10_1016_j_exger_2015_07_008 crossref_primary_10_1016_j_brainres_2018_06_027 crossref_primary_10_1016_j_neuroscience_2024_11_075 crossref_primary_10_1371_journal_pone_0150712 crossref_primary_10_1017_S1041610213001762 crossref_primary_10_1016_j_pnpbp_2017_10_020 crossref_primary_10_1016_j_pbb_2018_09_010 crossref_primary_10_1016_j_bbr_2016_06_011 crossref_primary_10_1007_s11920_024_01534_z crossref_primary_10_1016_j_bbr_2017_02_019 crossref_primary_10_3389_fncir_2022_895481 crossref_primary_10_1016_j_brainresbull_2017_07_011 crossref_primary_10_1093_ijnp_pyae006 crossref_primary_10_1080_21622965_2012_665774 crossref_primary_10_3389_fnmol_2024_1342622 crossref_primary_10_1016_j_biopsych_2011_03_010 crossref_primary_10_1038_npp_2013_6 crossref_primary_10_1146_annurev_clinpsy_050817_084903 crossref_primary_10_1016_j_biopsych_2011_01_027 crossref_primary_10_3389_fpsyg_2019_02096 crossref_primary_10_3389_fphar_2018_01485 crossref_primary_10_1016_j_neuropharm_2012_07_005 crossref_primary_10_1016_j_biopsych_2011_07_022 crossref_primary_10_3389_fnbeh_2016_00020 crossref_primary_10_1016_j_biopsych_2011_11_011 crossref_primary_10_1016_j_cobeha_2015_01_002 crossref_primary_10_3390_ijms23126602 crossref_primary_10_1016_j_bbr_2024_114963 crossref_primary_10_1016_j_pneurobio_2012_10_001 crossref_primary_10_1093_neuonc_not102 crossref_primary_10_1021_acsptsci_3c00077 crossref_primary_10_1016_j_expneurol_2024_114718 crossref_primary_10_1016_j_biopsych_2010_12_040 crossref_primary_10_1521_adhd_2018_26_5_1 crossref_primary_10_1007_s00213_016_4376_9 crossref_primary_10_1177_1039856213517949 crossref_primary_10_1016_j_neubiorev_2012_04_007 crossref_primary_10_1007_s11011_018_0190_x crossref_primary_10_1016_j_neuropharm_2012_07_020 crossref_primary_10_3390_life15030380 crossref_primary_10_1016_j_jneumeth_2015_02_002 crossref_primary_10_1016_j_exger_2014_11_006 crossref_primary_10_3389_fneur_2019_01414 crossref_primary_10_1111_jmwh_12671 crossref_primary_10_1016_j_mehy_2013_09_009 crossref_primary_10_3389_fnana_2015_00033 crossref_primary_10_1101_lm_033613_113 crossref_primary_10_1002_cpp_2645 crossref_primary_10_1016_j_biopsych_2014_09_013 crossref_primary_10_1016_j_tins_2015_12_009 crossref_primary_10_3109_08039488_2012_752035 crossref_primary_10_37489_2587_7836_2021_4_40_46 crossref_primary_10_1111_jnc_12743 crossref_primary_10_3758_s13415_022_01009_9 crossref_primary_10_12688_f1000research_160416_1 crossref_primary_10_1007_s10337_018_3610_5 crossref_primary_10_3390_molecules27082550 crossref_primary_10_1016_j_neubiorev_2016_09_002 crossref_primary_10_1586_era_11_202 crossref_primary_10_1016_j_neubiorev_2013_02_011 crossref_primary_10_1016_j_bbr_2015_05_009 crossref_primary_10_1124_pr_115_010512 crossref_primary_10_1016_j_pbb_2015_12_002 crossref_primary_10_1371_journal_pone_0088585 crossref_primary_10_1016_j_jchromb_2012_09_034 crossref_primary_10_1111_gbb_12270 crossref_primary_10_1016_j_bbr_2024_115002 crossref_primary_10_1155_2016_9730467 crossref_primary_10_1016_j_brainres_2015_11_024 crossref_primary_10_1177_1073858415602850 crossref_primary_10_1016_j_jad_2018_10_100 crossref_primary_10_1016_j_neurom_2025_01_003 crossref_primary_10_3389_fnimg_2023_1083036 crossref_primary_10_1159_000442383 crossref_primary_10_1038_s41467_022_31918_9 crossref_primary_10_1093_cercor_bht195 crossref_primary_10_3810_pgm_2012_09_2592 crossref_primary_10_1177_1087054712454192 crossref_primary_10_1007_s13311_012_0128_7 crossref_primary_10_1016_j_nicl_2021_102695 crossref_primary_10_1111_jnc_15470 crossref_primary_10_3390_biomedicines10010119 crossref_primary_10_1016_j_biopsych_2011_12_002 crossref_primary_10_1016_j_surfin_2024_104169 crossref_primary_10_1007_s00213_021_05974_w crossref_primary_10_3389_fnins_2020_557874 crossref_primary_10_1016_j_tins_2014_02_002 crossref_primary_10_1016_j_bbr_2012_12_025 crossref_primary_10_1186_s12915_021_01168_0 crossref_primary_10_1016_j_tics_2024_04_007 crossref_primary_10_1177_0883073814550498 crossref_primary_10_1007_s00520_019_04907_w crossref_primary_10_3389_fpsyg_2020_01991 crossref_primary_10_1016_j_bja_2022_08_037 |
| Cites_doi | 10.1016/0024-3205(93)90194-8 10.1542/peds.2006-3695 10.1046/j.1471-4159.1997.68052032.x 10.1016/S0165-6147(97)01063-8 10.1016/j.cell.2007.03.015 10.1002/ajmg.b.30142 10.1016/j.tins.2005.09.002 10.1016/j.biopsych.2007.03.003 10.1016/S0893-133X(98)00127-4 10.1152/jn.01310.2005 10.1017/S0033291700025332 10.1016/j.neuroscience.2005.09.031 10.1038/sj.mp.4000510 10.1016/0306-9877(89)90164-3 10.1186/1744-9081-1-2 10.1016/j.chc.2007.11.012 10.1016/j.conb.2008.01.003 10.1016/j.biopsych.2008.04.037 10.1523/JNEUROSCI.20-06-j0004.2000 10.1038/452674a 10.1176/ajp.94.3.577 10.1016/S0006-3223(99)00139-0 10.1177/070674370200601S07 10.1001/archpsyc.1980.01780210091010 10.1126/science.1100021 10.1002/cne.903210302 10.1001/archpsyc.1985.01790310108018 10.1016/j.neurobiolaging.2007.02.003 10.1111/j.1360-0443.2005.00944.x 10.1016/j.biopsych.2004.08.019 10.1097/00004583-199303000-00017 10.1111/j.1476-5381.1973.tb08331.x 10.1016/j.biopsych.2006.07.020 10.1016/S0022-3565(25)22757-4 10.1016/S1056-4993(18)30597-2 10.1007/s00213-008-1250-4 10.1016/S0065-3101(24)00289-5 10.1152/jn.1989.61.2.331 10.1176/appi.ajp.2007.05091676 10.1097/00004714-198706000-00004 10.1016/S0022-3565(24)38829-9 10.1016/j.neuroscience.2005.06.005 10.1523/JNEUROSCI.2446-04.2004 10.1016/S0165-0173(03)00143-7 10.1016/0006-8993(75)90233-4 10.1097/00004583-199709000-00012 10.1037/0033-295X.94.4.469 10.1097/00004583-199501000-00013 10.1038/nrn896 10.1097/01.chi.0000128797.91601.1a 10.1037/0735-7044.111.5.883 10.1073/pnas.95.24.14494 10.1002/syn.10038 10.1002/cne.10898 10.1016/j.brainresrev.2007.10.013 10.1097/00004583-198709000-00011 10.1016/S0166-4328(89)80005-1 10.1542/peds.2008-1597 10.1002/syn.10131 10.1002/syn.890110210 10.1124/jpet.106.110015 10.1016/0165-1781(83)90006-9 10.1016/S0893-133X(00)00111-1 10.1016/j.biopsych.2005.01.034 10.1016/j.brainresrev.2010.03.003 10.1016/S0010-9452(08)70426-X 10.1176/ajp.141.7.906 10.1016/S0079-6123(00)26014-7 10.1016/0014-2999(77)90202-3 10.1523/JNEUROSCI.5024-08.2009 10.1523/JNEUROSCI.15-02-01308.1995 10.1176/appi.ajp.158.7.1067 10.1523/JNEUROSCI.22-16-07264.2002 10.1093/cercor/bhm033 10.1016/S0166-4328(01)00204-2 10.1002/ajmg.b.30636 10.1523/JNEUROSCI.0195-04.2004 10.1038/sj.npp.1301164 10.1073/pnas.0707741104 10.1016/j.biopsych.2005.05.022 10.1002/ajmg.10194 10.1007/s00439-009-0694-x 10.1016/j.tins.2004.06.006 10.1016/0028-3908(93)90165-Y 10.1016/j.biopsych.2006.04.022 10.1016/S0006-3223(99)00138-9 10.1001/archpsyc.63.4.462 10.1016/S0893-133X(98)00112-2 10.1176/ajp.155.5.693 10.1016/S0166-4328(97)00175-7 10.1007/BF00174372 10.1038/sj.npp.1301159 10.1001/archpsyc.1996.01830050084013 10.1016/j.jaac.2010.06.015 10.1016/S0022-3565(25)20085-4 10.1097/00004583-198909000-00022 10.1111/j.1471-4159.1990.tb04599.x 10.1016/0149-7634(84)90030-7 10.1542/peds.2008-0931 10.1016/S0022-3565(25)33153-8 10.1007/BF02246109 10.1523/JNEUROSCI.18-07-02697.1998 10.1146/annurev.neuro.28.061604.135709 10.1126/science.173.3997.652 10.1089/10445460050167304 10.1016/j.conb.2004.06.007 10.1016/0006-8993(94)91570-9 10.1002/cne.20738 10.1542/peds.111.1.179 10.1523/JNEUROSCI.1573-04.2004 10.1016/j.neubiorev.2004.09.006 10.1007/s002130050533 10.1097/01.chi.0000128796.84202.eb 10.1038/nn1846 10.1038/350610a0 10.1016/S0002-7138(09)60065-0 10.1016/S0006-3223(02)01671-2 10.1016/S0893-133X(02)00346-9 |
| ContentType | Journal Article |
| Copyright | 2011 Society of Biological Psychiatry Society of Biological Psychiatry Copyright © 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2011 Society of Biological Psychiatry – notice: Society of Biological Psychiatry – notice: Copyright © 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.1016/j.biopsych.2010.06.023 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Biology |
| EISSN | 1873-2402 |
| EndPage | e111 |
| ExternalDocumentID | PMC3012746 20875636 10_1016_j_biopsych_2010_06_023 S0006322310006785 1_s2_0_S0006322310006785 |
| Genre | Research Support, U.S. Gov't, Non-P.H.S Review Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIDA NIH HHS grantid: DA000389 – fundername: NIMH NIH HHS grantid: MH081843 – fundername: NIDA NIH HHS grantid: K02 DA000389 – fundername: Intramural NIH HHS grantid: Z01 DA000389 – fundername: NIMH NIH HHS grantid: R01 MH081843 |
| GroupedDBID | --- --K --M -DZ .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABCQX ABDPE ABFNM ABFRF ABIVO ABJNI ABLJU ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACIEU ACIUM ACNCT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEG HMK HMO HMQ HVGLF HZ~ H~9 IHE J1W KOM L7B M29 M2V M39 M41 MO0 MOBAO N9A O-L O9- OAUVE OH0 OU- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SNS SPCBC SSH SSN SSZ T5K UAP UNMZH UPT UV1 WH7 WUQ XJT XOL Z5R ZCA ZGI ZKB ZXP ~G- AACTN AFCTW AFKWA AJOXV AMFUW PKN RIG AADPK AAIAV ABLVK ABYKQ AJBFU EFLBG G8K LCYCR ZA5 AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c598t-8e8575eb3efafff94d28384647aeee29b0f8070a697df0a1b8186fd06ded4a4c3 |
| IEDL.DBID | .~1 |
| ISSN | 0006-3223 1873-2402 |
| IngestDate | Thu Aug 21 13:43:38 EDT 2025 Mon Jul 21 10:30:52 EDT 2025 Mon Jul 21 06:01:20 EDT 2025 Thu Apr 24 23:12:08 EDT 2025 Sun Jul 06 05:06:36 EDT 2025 Fri Feb 23 02:26:54 EST 2024 Sun Feb 23 10:19:38 EST 2025 Tue Aug 26 16:31:51 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Keywords | norepinephrine ADHD stimulants cognition dopamine prefrontal cortex |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c598t-8e8575eb3efafff94d28384647aeee29b0f8070a697df0a1b8186fd06ded4a4c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 20875636 |
| PQID | 870547007 |
| PQPubID | 23479 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3012746 proquest_miscellaneous_870547007 pubmed_primary_20875636 crossref_citationtrail_10_1016_j_biopsych_2010_06_023 crossref_primary_10_1016_j_biopsych_2010_06_023 elsevier_sciencedirect_doi_10_1016_j_biopsych_2010_06_023 elsevier_clinicalkeyesjournals_1_s2_0_S0006322310006785 elsevier_clinicalkey_doi_10_1016_j_biopsych_2010_06_023 |
| PublicationCentury | 2000 |
| PublicationDate | 2011-06-15 |
| PublicationDateYYYYMMDD | 2011-06-15 |
| PublicationDate_xml | – month: 06 year: 2011 text: 2011-06-15 day: 15 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Biological psychiatry (1969) |
| PublicationTitleAlternate | Biol Psychiatry |
| PublicationYear | 2011 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Arnsten (bib25) 2006; 31 Greenhill (bib8) 2001 Rapoport, Zametkin, Donnelly, Ismond (bib78) 1985; 21 Winsberg, Camp-Bruno, Vink, Timmer, Sverd (bib125) 1987; 7 Barkley, Biederman (bib24) 1997; 36 Hechtman, Abikoff, Klein, Weiss, Respitz, Kouri (bib9) 2004; 43 Spencer, Biederman, Kerman, Steingard, Wilens (bib79) 1993; 32 Berridge, Devilbiss, Andrzejewski, Arnsten, Kelley, Schmeichel (bib21) 2006; 60 Arnsten, Steere, Hunt (bib114) 1996; 53 Rapoport, Inoff-Germain (bib18) 2002; 6 Wang, Ramos, Paspalas, Shu, Simen, Duque (bib103) 2007; 129 Wender, Wood, Reimherr, Ward (bib105) 1983; 9 Gamo NJ, Wang M, Arnsten AFT (in press): Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors. Arnsten (bib91) 2000; 126 Wise, Bozarth (bib50) 1987; 94 Miner, Schroeter, Blakely, Sesack (bib67) 2003; 466 Jakala, Riekkinen, Sirvio, Koivisto, Kejonen, Vanhanen, Riekkinen (bib97) 1999; 20 Gastfriend, Biederman, Jellinek (bib82) 1984; 141 Daly, Hawi, Fitzgerald, Gill (bib127) 1999; 4 Wender, Reimherr, Wood (bib11) 1985; 42 Pratt, Mizumori (bib43) 2001; 123 Roman, Schmitz, Polanczyk, Eizirik, Rohde, Hutz (bib128) 2002; 114 Johnson, van der Meer, Redish (bib44) 2007; 17 Mill, Caspi, Williams, Craig, Taylor, Polo-Tomas (bib132) 2006; 63 Zerbe, Rowe, Enas, Wong, Farid, Lemberger (bib85) 1985; 232 Bellgrove, Hawi, Gill, Robertson (bib129) 2006; 42 Yang, Seamans, Gorelova (bib108) 1999; 21 Rapoport, Buchsbaum, Weingartner, Zahn, Ludlow, Mikkelsen (bib14) 1980; 37 Berridge (bib53) 2008; 58 Kuczenski, Segal (bib37) 1997; 68 Prince, Wilens, Biederman, Spencer, Millstein, Polisner, Bostic (bib80) 2000; 10 . Steere, Arnsten (bib100) 1997; 111 Vaidya, Austin, Kirkorian, Ridlehuber, Desmond, Glover, Gabrieli (bib15) 1998; 95 Smiley, Williams, Szigeti, Goldman-Rakic (bib122) 1992; 321 Agnati, Guidolin, Guescini, Genedani, Fuxe (bib65) 2010; 64 Dalley, Cardinal, Robbins (bib42) 2004; 28 MacDonald, Kobilka, Scheinin (bib92) 1997; 18 Shenker (bib104) 1992; 39 Berridge (bib52) 2006; 31 Kelley, Gauthier, Lang (bib51) 1989; 35 Mefford, Potter (bib107) 1989; 29 Berridge, Arnsten, Foote (bib102) 1993; 23 Carboni, Tanda, Frau, Di (bib40) 1990; 55 Lundqvist (bib72) 2009; vol 3 Scheffler, Brown, Fulton, Hinshaw, Levine, Stone (bib10) 2009; 123 Shaw, Eckstrand, Sharp, Blumenthal, Lerch, Greenstein (bib28) 2007; 104 Berridge, Waterhouse (bib56) 2003; 42 Hunt, Arnsten, Asbell (bib94) 1995; 34 Kuczenski, Segal (bib33) 1992; 11 Funahashi, Bruce, Goldman-Rakic (bib121) 1989; 61 Mao, Arnsten, Li (bib99) 1999; 46 Mehta, Sahakian, Robbins (bib17) 2001 Biederman, Baldessarini, Wright, Knee, Harmatz (bib76) 1989; 28 Wong, Threlkeld, Best, Bymaster (bib81) 1982; 222 Vijayraghavan, Wang, Birnbaum, Williams, Arnsten (bib119) 2007; 10 McCabe, Knight, Teter, Wechsler (bib31) 2005; 100 Bolden-Watson, Richelson (bib75) 1993; 52 Spencer, Biederman, Wilens, Prince, Hatch, Jones (bib83) 1998; 155 Devilbiss, Waterhouse (bib60) 2002 Drouin, Page, Waterhouse (bib39) 2006; 96 Abikoff, Hechtman, Klein, Gallagher, Fleiss, Etcovitch (bib12) 2004; 43 Solanto (bib23) 1998; 94 Birnbaum, Yuan, Wang, Vijayraghavan, Bloom, Davis (bib116) 2004; 306 Bradley (bib7) 1937; 94 Arnsten, Li (bib58) 2005; 57 Newcorn, Kratochvil, Allen, Casat, Ruff, Moore, Michelson (bib13) 2008; 165 Arnsten, Dudley (bib5) 2005; 1 Gastfriend, Biederman, Jellinek (bib77) 1985; 21 Van Tol, Bunzow, Guan, Sunahara, Seeman, Niznik, Civelli (bib111) 1991; 350 Hurley, Devilbiss, Waterhouse (bib61) 2004; 14 Devilbiss, Berridge (bib64) 2006; 319 Bush, Valera, Seidman (bib29) 2005; 57 Kuczenski, Segal (bib38) 2001; 296 Horn (bib89) 1973; 47 Aston-Jones, Cohen (bib69) 2005; 28 Kieling, Genro, Hutz, Rohde (bib130) 2008; 147B Ramos, Colgan, Nou, Ovadia, Wilson, Arnsten (bib117) 2005; 58 Kieling, Goncalves, Tannock, Castellanos (bib27) 2008; 17 Avery, Franowicz, Studholme, van Dyck, Arnsten (bib101) 2000; 23 Bouret, Sara (bib70) 2005; 28 Biederman, Melmed, Patel, McBurnett, Konow, Lyne, Scherer (bib96) 2008; 121 Gizer, Ficks, Waldman (bib131) 2009; 126 Baldessarini (bib74) 1985 Lapiz, Morilak (bib123) 2006; 137 Berridge (bib59) 2008 Carr, White (bib49) 1986; 89 Swanson, Volkow (bib19) 2001 Bobb, Addington, Sidransky, Gornick, Lerch, Greenstein (bib126) 2005; 134B Paspalas, Goldman-Rakic (bib110) 2004; 24 Mehta, Owen, Sahakian, Mavaddat, Pickard, Robbins (bib16) 2000; 20 Pitts, Marwah (bib62) 1987; 240 Gabbott, Warner, Jays, Salway, Busby (bib46) 2005; 492 Rebec, Bashore (bib2) 1984; 8 Zdrale, Meier, Berridge, Populin (bib22) 2008 Wilens, Faraone, Biederman, Gunawardene (bib55) 2003; 111 Green (bib73) 1992; 1 McGaughy, Sarter (bib3) 1995; 117 Arnsten (bib112) 2007; 17 Postle (bib113) 2006; 139 Ramos, Colgan, Nou, Arnsten (bib118) 2008; 29 Biederman (bib54) 2003; 64 Kuczenski, Segal (bib35) 1994 Scahill, Chappell, Kim, Schultz, Katsovich, Shepherd (bib95) 2001; 158 Kuczenski, Segal (bib20) 2002; 22 Kuczenski, Segal, Cho, Melega (bib34) 1995; 15 Florin, Kuczenski, Segal (bib36) 1994; 654 Setlik, Bond, Ho (bib30) 2009; 124 Devilbiss, Waterhouse (bib66) 2004; 24 Devilbiss, Berridge (bib6) 2008; 64 Maher (bib32) 2008; 452 Chamberlain, Del, Dowson, Muller, Clark, Robbins, Sahakian (bib86) 2007; 62 Michelson, Adler, Spencer, Reimherr, West, Allen (bib84) 2003; 53 Fuster, Alexander (bib120) 1971; 173 Hunt, Minderaa, Cohen (bib93) 1985; 24 Raiteri, del, Bertollini, Levi (bib90) 1977; 41 Clark, Blackwell, Aron, Turner, Dowson, Robbins, Sahakian (bib71) 2007; 61 Voorn, Vanderschuren, Groenewegen, Robbins, Pennartz (bib45) 2004; 27 Clayton, Rajkowski, Cohen, Ston-Jones (bib57) 2004; 24 Birnbaum, Gobeske, Auerbach, Taylor, Arnsten (bib115) 1999; 46 Lewis (bib109) 2001 Volkow, Wang, Fowler, Logan, Franceschi, Maynard (bib47) 2002; 43 Eckhoff, Wong-Lin, Holmes (bib68) 2009; 29 Segal (bib1) 1975; 13 Bymaster, Katner, Nelson, Hemrick-Luecke, Threlkeld, Heiligenstein (bib88) 2002; 27 Castellanos, Tannock (bib26) 2002; 3 Curtis, Conti, Valentino (bib63) 1993; 32 Seu, Lang, Rivera, Jentsch (bib87) 2009; 202 Berridge, Stalnaker (bib4) 2002; 46 Franowicz, Arnsten (bib98) 1998; 136 Sesack, Hawrylak, Matus, Guido, Levey (bib41) 1998; 18 Kelly, Seviour, Iversen (bib48) 1975; 94 Zametkin, Rapoport (bib106) 1987; 26 McGaughy (10.1016/j.biopsych.2010.06.023_bib3) 1995; 117 Daly (10.1016/j.biopsych.2010.06.023_bib127) 1999; 4 Dalley (10.1016/j.biopsych.2010.06.023_bib42) 2004; 28 Biederman (10.1016/j.biopsych.2010.06.023_bib54) 2003; 64 Birnbaum (10.1016/j.biopsych.2010.06.023_bib116) 2004; 306 Paspalas (10.1016/j.biopsych.2010.06.023_bib110) 2004; 24 10.1016/j.biopsych.2010.06.023_bib124 McCabe (10.1016/j.biopsych.2010.06.023_bib31) 2005; 100 Sesack (10.1016/j.biopsych.2010.06.023_bib41) 1998; 18 Kuczenski (10.1016/j.biopsych.2010.06.023_bib37) 1997; 68 Bobb (10.1016/j.biopsych.2010.06.023_bib126) 2005; 134B Hurley (10.1016/j.biopsych.2010.06.023_bib61) 2004; 14 Rapoport (10.1016/j.biopsych.2010.06.023_bib14) 1980; 37 Kuczenski (10.1016/j.biopsych.2010.06.023_bib34) 1995; 15 Gabbott (10.1016/j.biopsych.2010.06.023_bib46) 2005; 492 Gastfriend (10.1016/j.biopsych.2010.06.023_bib82) 1984; 141 Chamberlain (10.1016/j.biopsych.2010.06.023_bib86) 2007; 62 Arnsten (10.1016/j.biopsych.2010.06.023_bib5) 2005; 1 Vijayraghavan (10.1016/j.biopsych.2010.06.023_bib119) 2007; 10 Horn (10.1016/j.biopsych.2010.06.023_bib89) 1973; 47 Berridge (10.1016/j.biopsych.2010.06.023_bib4) 2002; 46 Clark (10.1016/j.biopsych.2010.06.023_bib71) 2007; 61 Smiley (10.1016/j.biopsych.2010.06.023_bib122) 1992; 321 Mao (10.1016/j.biopsych.2010.06.023_bib99) 1999; 46 Florin (10.1016/j.biopsych.2010.06.023_bib36) 1994; 654 Segal (10.1016/j.biopsych.2010.06.023_bib1) 1975; 13 Kuczenski (10.1016/j.biopsych.2010.06.023_bib33) 1992; 11 Roman (10.1016/j.biopsych.2010.06.023_bib128) 2002; 114 Kuczenski (10.1016/j.biopsych.2010.06.023_bib38) 2001; 296 Arnsten (10.1016/j.biopsych.2010.06.023_bib25) 2006; 31 Bush (10.1016/j.biopsych.2010.06.023_bib29) 2005; 57 MacDonald (10.1016/j.biopsych.2010.06.023_bib92) 1997; 18 Fuster (10.1016/j.biopsych.2010.06.023_bib120) 1971; 173 Arnsten (10.1016/j.biopsych.2010.06.023_bib91) 2000; 126 Shaw (10.1016/j.biopsych.2010.06.023_bib28) 2007; 104 Biederman (10.1016/j.biopsych.2010.06.023_bib76) 1989; 28 Franowicz (10.1016/j.biopsych.2010.06.023_bib98) 1998; 136 Mehta (10.1016/j.biopsych.2010.06.023_bib16) 2000; 20 Biederman (10.1016/j.biopsych.2010.06.023_bib96) 2008; 121 Berridge (10.1016/j.biopsych.2010.06.023_bib21) 2006; 60 Rapoport (10.1016/j.biopsych.2010.06.023_bib78) 1985; 21 Wender (10.1016/j.biopsych.2010.06.023_bib105) 1983; 9 Avery (10.1016/j.biopsych.2010.06.023_bib101) 2000; 23 Van Tol (10.1016/j.biopsych.2010.06.023_bib111) 1991; 350 Lapiz (10.1016/j.biopsych.2010.06.023_bib123) 2006; 137 Arnsten (10.1016/j.biopsych.2010.06.023_bib58) 2005; 57 Johnson (10.1016/j.biopsych.2010.06.023_bib44) 2007; 17 Scheffler (10.1016/j.biopsych.2010.06.023_bib10) 2009; 123 Bradley (10.1016/j.biopsych.2010.06.023_bib7) 1937; 94 Michelson (10.1016/j.biopsych.2010.06.023_bib84) 2003; 53 Raiteri (10.1016/j.biopsych.2010.06.023_bib90) 1977; 41 Abikoff (10.1016/j.biopsych.2010.06.023_bib12) 2004; 43 Mehta (10.1016/j.biopsych.2010.06.023_bib17) 2001 Wong (10.1016/j.biopsych.2010.06.023_bib81) 1982; 222 Zametkin (10.1016/j.biopsych.2010.06.023_bib106) 1987; 26 Green (10.1016/j.biopsych.2010.06.023_bib73) 1992; 1 Birnbaum (10.1016/j.biopsych.2010.06.023_bib115) 1999; 46 Wang (10.1016/j.biopsych.2010.06.023_bib103) 2007; 129 Arnsten (10.1016/j.biopsych.2010.06.023_bib112) 2007; 17 Rebec (10.1016/j.biopsych.2010.06.023_bib2) 1984; 8 Spencer (10.1016/j.biopsych.2010.06.023_bib79) 1993; 32 Swanson (10.1016/j.biopsych.2010.06.023_bib19) 2001 Vaidya (10.1016/j.biopsych.2010.06.023_bib15) 1998; 95 Kieling (10.1016/j.biopsych.2010.06.023_bib130) 2008; 147B Devilbiss (10.1016/j.biopsych.2010.06.023_bib6) 2008; 64 Carr (10.1016/j.biopsych.2010.06.023_bib49) 1986; 89 Funahashi (10.1016/j.biopsych.2010.06.023_bib121) 1989; 61 Ramos (10.1016/j.biopsych.2010.06.023_bib117) 2005; 58 Berridge (10.1016/j.biopsych.2010.06.023_bib102) 1993; 23 Newcorn (10.1016/j.biopsych.2010.06.023_bib13) 2008; 165 Seu (10.1016/j.biopsych.2010.06.023_bib87) 2009; 202 Kelley (10.1016/j.biopsych.2010.06.023_bib51) 1989; 35 Lundqvist (10.1016/j.biopsych.2010.06.023_bib72) 2009; vol 3 Pratt (10.1016/j.biopsych.2010.06.023_bib43) 2001; 123 Voorn (10.1016/j.biopsych.2010.06.023_bib45) 2004; 27 Eckhoff (10.1016/j.biopsych.2010.06.023_bib68) 2009; 29 Kelly (10.1016/j.biopsych.2010.06.023_bib48) 1975; 94 Aston-Jones (10.1016/j.biopsych.2010.06.023_bib69) 2005; 28 Mill (10.1016/j.biopsych.2010.06.023_bib132) 2006; 63 Berridge (10.1016/j.biopsych.2010.06.023_bib59) 2008 Bolden-Watson (10.1016/j.biopsych.2010.06.023_bib75) 1993; 52 Lewis (10.1016/j.biopsych.2010.06.023_bib109) 2001 Winsberg (10.1016/j.biopsych.2010.06.023_bib125) 1987; 7 Zdrale (10.1016/j.biopsych.2010.06.023_bib22) 2008 Pitts (10.1016/j.biopsych.2010.06.023_bib62) 1987; 240 Gizer (10.1016/j.biopsych.2010.06.023_bib131) 2009; 126 Bymaster (10.1016/j.biopsych.2010.06.023_bib88) 2002; 27 Ramos (10.1016/j.biopsych.2010.06.023_bib118) 2008; 29 Clayton (10.1016/j.biopsych.2010.06.023_bib57) 2004; 24 Scahill (10.1016/j.biopsych.2010.06.023_bib95) 2001; 158 Castellanos (10.1016/j.biopsych.2010.06.023_bib26) 2002; 3 Zerbe (10.1016/j.biopsych.2010.06.023_bib85) 1985; 232 Wise (10.1016/j.biopsych.2010.06.023_bib50) 1987; 94 Shenker (10.1016/j.biopsych.2010.06.023_bib104) 1992; 39 Devilbiss (10.1016/j.biopsych.2010.06.023_bib60) 2002 Agnati (10.1016/j.biopsych.2010.06.023_bib65) 2010; 64 Wender (10.1016/j.biopsych.2010.06.023_bib11) 1985; 42 Bellgrove (10.1016/j.biopsych.2010.06.023_bib129) 2006; 42 Solanto (10.1016/j.biopsych.2010.06.023_bib23) 1998; 94 Carboni (10.1016/j.biopsych.2010.06.023_bib40) 1990; 55 Kuczenski (10.1016/j.biopsych.2010.06.023_bib20) 2002; 22 Barkley (10.1016/j.biopsych.2010.06.023_bib24) 1997; 36 Yang (10.1016/j.biopsych.2010.06.023_bib108) 1999; 21 Rapoport (10.1016/j.biopsych.2010.06.023_bib18) 2002; 6 Devilbiss (10.1016/j.biopsych.2010.06.023_bib64) 2006; 319 Postle (10.1016/j.biopsych.2010.06.023_bib113) 2006; 139 Gastfriend (10.1016/j.biopsych.2010.06.023_bib77) 1985; 21 Berridge (10.1016/j.biopsych.2010.06.023_bib53) 2008; 58 Hunt (10.1016/j.biopsych.2010.06.023_bib94) 1995; 34 Volkow (10.1016/j.biopsych.2010.06.023_bib47) 2002; 43 Arnsten (10.1016/j.biopsych.2010.06.023_bib114) 1996; 53 Wilens (10.1016/j.biopsych.2010.06.023_bib55) 2003; 111 Devilbiss (10.1016/j.biopsych.2010.06.023_bib66) 2004; 24 Kuczenski (10.1016/j.biopsych.2010.06.023_bib35) 1994 Greenhill (10.1016/j.biopsych.2010.06.023_bib8) 2001 Berridge (10.1016/j.biopsych.2010.06.023_bib56) 2003; 42 Kieling (10.1016/j.biopsych.2010.06.023_bib27) 2008; 17 Berridge (10.1016/j.biopsych.2010.06.023_bib52) 2006; 31 Jakala (10.1016/j.biopsych.2010.06.023_bib97) 1999; 20 Drouin (10.1016/j.biopsych.2010.06.023_bib39) 2006; 96 Curtis (10.1016/j.biopsych.2010.06.023_bib63) 1993; 32 Miner (10.1016/j.biopsych.2010.06.023_bib67) 2003; 466 Spencer (10.1016/j.biopsych.2010.06.023_bib83) 1998; 155 Steere (10.1016/j.biopsych.2010.06.023_bib100) 1997; 111 Hechtman (10.1016/j.biopsych.2010.06.023_bib9) 2004; 43 Baldessarini (10.1016/j.biopsych.2010.06.023_bib74) 1985 Prince (10.1016/j.biopsych.2010.06.023_bib80) 2000; 10 Maher (10.1016/j.biopsych.2010.06.023_bib32) 2008; 452 Hunt (10.1016/j.biopsych.2010.06.023_bib93) 1985; 24 Bouret (10.1016/j.biopsych.2010.06.023_bib70) 2005; 28 Mefford (10.1016/j.biopsych.2010.06.023_bib107) 1989; 29 Setlik (10.1016/j.biopsych.2010.06.023_bib30) 2009; 124 |
| References_xml | – volume: 42 start-page: 840 year: 1985 ident: bib11 article-title: Stimulant therapy of “adult hyperactivity” publication-title: Arch Gen Psychiatry – start-page: 81 year: 1994 end-page: 113 ident: bib35 article-title: Neurochemistry of amphetamine publication-title: Amphetamine and Its Analogues: Psychopharmacology, Toxicology and Abuse – volume: 18 start-page: 2697 year: 1998 end-page: 2708 ident: bib41 article-title: Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter publication-title: J Neurosci – volume: 466 start-page: 478 year: 2003 end-page: 494 ident: bib67 article-title: Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals publication-title: J Comp Neurol – volume: 126 start-page: 183 year: 2000 end-page: 192 ident: bib91 article-title: Stress impairs prefrontal cortical function in rats and monkeys: Role of dopamine D1 and norepinephrine alpha-1 receptor mechanisms publication-title: Prog Brain Res – volume: 24 start-page: 5292 year: 2004 end-page: 5300 ident: bib110 article-title: Microdomains for dopamine volume neurotransmission in primate prefrontal cortex publication-title: J Neurosci – volume: 42 start-page: 838 year: 2006 end-page: 845 ident: bib129 article-title: The cognitive genetics of attention deficit hyperactivity disorder (ADHD): Sustained attention as a candidate phenotype publication-title: Cortex – volume: 64 start-page: 626 year: 2008 end-page: 635 ident: bib6 article-title: Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness publication-title: Biol Psychiatry – volume: 58 start-page: 894 year: 2005 end-page: 900 ident: bib117 article-title: The beta-1 adrenergic antagonist, betaxolol, improves working memory performance in rats and monkeys publication-title: Biol Psychiatry – volume: 654 start-page: 53 year: 1994 end-page: 62 ident: bib36 article-title: Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment publication-title: Brain Res – volume: 492 start-page: 145 year: 2005 end-page: 177 ident: bib46 article-title: Prefrontal cortex in the rat: Projections to subcortical autonomic, motor, and limbic centers publication-title: J Comp Neurol – volume: 53 start-page: 112 year: 2003 end-page: 120 ident: bib84 article-title: Atomoxetine in adults with ADHD: Two randomized, placebo-controlled studies publication-title: Biol Psychiatry – volume: 42 start-page: 33 year: 2003 end-page: 84 ident: bib56 article-title: The locus coeruleus-noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes publication-title: Brain Res Brain Res Rev – volume: 39 start-page: 337 year: 1992 end-page: 382 ident: bib104 article-title: The mechanism of action of drugs used to treat attention-deficit hyperactivity disorder: Focus on catecholamine receptor pharmacology publication-title: Adv Pediatr – volume: 46 start-page: 140 year: 2002 end-page: 149 ident: bib4 article-title: Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex publication-title: Synapse – volume: 43 start-page: 820 year: 2004 end-page: 829 ident: bib12 article-title: Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment publication-title: J Am Acad Child Adolesc Psychiatry – volume: 36 start-page: 1204 year: 1997 end-page: 1210 ident: bib24 article-title: Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder publication-title: J Am Acad Child Adolesc Psychiatry – volume: 46 start-page: 1266 year: 1999 end-page: 1274 ident: bib115 article-title: A role for norepinephrine in stress-induced cognitive deficits: Alpha-1-adrenoceptor mediation in the prefrontal cortex publication-title: Biol Psychiatry – volume: 57 start-page: 1273 year: 2005 end-page: 1284 ident: bib29 article-title: Functional neuroimaging of attention-deficit/hyperactivity disorder: A review and suggested future directions publication-title: Biol Psychiatry – volume: 1 start-page: 449 year: 1992 end-page: 465 ident: bib73 article-title: Nonstimulant drugs in the treatment of attention-deficit hyperactivity disorder publication-title: Child Adolesc Psychiatr Clin N Am – volume: 41 start-page: 133 year: 1977 end-page: 143 ident: bib90 article-title: Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine publication-title: Eur J Pharmacol – volume: 9 start-page: 329 year: 1983 end-page: 336 ident: bib105 article-title: An open trial of pargyline in the treatment of attention deficit disorder, residual type publication-title: Psychiatry Res – volume: 126 start-page: 51 year: 2009 end-page: 90 ident: bib131 article-title: Candidate gene studies of ADHD: A meta-analytic review publication-title: Hum Genet – volume: 58 start-page: 1 year: 2008 end-page: 17 ident: bib53 article-title: Noradrenergic modulation of arousal publication-title: Brain Res Rev – volume: 8 start-page: 153 year: 1984 end-page: 159 ident: bib2 article-title: Critical issues in assessing the behavioral effects of amphetamine publication-title: Neurosci Biobehav Rev – volume: 21 start-page: 144 year: 1985 end-page: 145 ident: bib77 article-title: Desipramine in the treatment of attention deficit disorder in adolescents publication-title: Psychopharmacol Bull – volume: 43 start-page: 181 year: 2002 end-page: 187 ident: bib47 article-title: Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications publication-title: Synapse – volume: 23 start-page: 240 year: 2000 end-page: 249 ident: bib101 article-title: The alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory task publication-title: Neuropsychopharmacology – volume: 111 start-page: 179 year: 2003 end-page: 185 ident: bib55 article-title: Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? publication-title: Pediatrics – year: 2008 ident: bib59 article-title: The locus coeruleus-noradrenergic system and stress: Implications for post-traumatic stress disorder (PTSD) publication-title: Posttraumatic Stress Disorder: Basic Science and Clinical Practice – volume: 28 start-page: 403 year: 2005 end-page: 450 ident: bib69 article-title: An integrative theory of locus coeruleus-norepinephrine function: Adaptive gain and optimal performance publication-title: Annu Rev Neurosci – volume: 55 start-page: 1067 year: 1990 end-page: 1070 ident: bib40 article-title: Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: Evidence that dopamine is taken up in vivo by noradrenergic terminals publication-title: J Neurochem – volume: 94 start-page: 127 year: 1998 end-page: 152 ident: bib23 article-title: Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration publication-title: Behav Brain Res – volume: 96 start-page: 622 year: 2006 end-page: 632 ident: bib39 article-title: Methylphenidate enhances noradrenergic transmission and suppresses mid- and long-latency sensory responses in the primary somatosensory cortex of awake rats publication-title: J Neurophysiol – volume: 155 start-page: 693 year: 1998 end-page: 695 ident: bib83 article-title: Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder publication-title: Am J Psychiatry – volume: 10 start-page: 376 year: 2007 end-page: 384 ident: bib119 article-title: Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory publication-title: Nat Neurosci – reference: Gamo NJ, Wang M, Arnsten AFT (in press): Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors. – year: 2008 ident: bib22 article-title: Effect of methylphenidate on monkey prefrontal cortex-mediated behavior – volume: 134B start-page: 67 year: 2005 end-page: 72 ident: bib126 article-title: Support for association between ADHD and two candidate genes: NET1 and DRD1 publication-title: Am J Med Genet B Neuropsychiatr Genet – volume: 202 start-page: 505 year: 2009 end-page: 519 ident: bib87 article-title: Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys publication-title: Psychopharmacology (Berl) – volume: 21 start-page: 161 year: 1999 end-page: 194 ident: bib108 article-title: Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex publication-title: Neuropsychopharmacology – reference: . – volume: 350 start-page: 610 year: 1991 end-page: 614 ident: bib111 article-title: Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine publication-title: Nature – volume: 14 start-page: 488 year: 2004 end-page: 495 ident: bib61 article-title: A matter of focus: Monoaminergic modulation of stimulus coding in mammalian sensory networks publication-title: Curr Opin Neurobiol – year: 1985 ident: bib74 article-title: Antidepressant agents publication-title: Chemotherapy in Psychiatry – volume: 43 start-page: 812 year: 2004 end-page: 819 ident: bib9 article-title: Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment publication-title: J Am Acad Child Adolesc Psychiatry – volume: 34 start-page: 50 year: 1995 end-page: 54 ident: bib94 article-title: An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder publication-title: J Am Acad Child Adolesc Psychiatry – volume: 20 start-page: 460 year: 1999 end-page: 470 ident: bib97 article-title: Guanfacine, but not clonidine, improves planning and working memory performance in humans publication-title: Neuropsychopharmacology – volume: 117 start-page: 340 year: 1995 end-page: 357 ident: bib3 article-title: Behavioral vigilance in rats: Task validation and effects of age, amphetamine, and benzodiazepine receptor ligands publication-title: Psychopharmacology (Berl) – volume: 165 start-page: 721 year: 2008 end-page: 730 ident: bib13 article-title: Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: Acute comparison and differential response publication-title: Am J Psychiatry – volume: 64 start-page: 3 year: 2003 end-page: 8 ident: bib54 article-title: Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: Findings from a longitudinal follow-up of youths with and without ADHD publication-title: J Clin Psychiatry – volume: 7 start-page: 143 year: 1987 end-page: 147 ident: bib125 article-title: Mianserin pharmacokinetics and behavior in hyperkinetic children publication-title: J Clin Psychopharmacol – volume: 18 start-page: 211 year: 1997 end-page: 219 ident: bib92 article-title: Gene targeting—homing in on alpha 2-adrenoceptor-subtype function publication-title: Trends Pharmacol Sci – start-page: 77 year: 2001 end-page: 103 ident: bib109 article-title: The catecholamine innervation of primate cerebral cortex publication-title: Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. – volume: 137 start-page: 1039 year: 2006 end-page: 1049 ident: bib123 article-title: Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability publication-title: Neuroscience – volume: 28 start-page: 771 year: 2004 end-page: 784 ident: bib42 article-title: Prefrontal executive and cognitive functions in rodents: Neural and neurochemical substrates publication-title: Neurosci Biobehav Rev – volume: 10 start-page: 193 year: 2000 end-page: 204 ident: bib80 article-title: A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder publication-title: J Child Adolesc Psychopharmacol – volume: 22 start-page: 7264 year: 2002 end-page: 7271 ident: bib20 article-title: Exposure of adolescent rats to oral methylphenidate: Preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine publication-title: J Neurosci – volume: 296 start-page: 876 year: 2001 end-page: 883 ident: bib38 article-title: Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: Relative roles of dopamine and norepinephrine publication-title: J Pharmacol Exp Ther – volume: 27 start-page: 699 year: 2002 end-page: 711 ident: bib88 article-title: Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit/hyperactivity disorder publication-title: Neuropsychopharmacology – volume: 26 start-page: 676 year: 1987 end-page: 686 ident: bib106 article-title: Neurobiology of attention deficit disorder with hyperactivity: Where have we come in 50 years? publication-title: J Am Acad Child Adolesc Psychiatry – volume: 147B start-page: 485 year: 2008 end-page: 490 ident: bib130 article-title: The -1021 C/T DBH polymorphism is associated with neuropsychological performance among children and adolescents with ADHD publication-title: Am J Med Genet B Neuropsychiatr Genet – volume: 27 start-page: 468 year: 2004 end-page: 474 ident: bib45 article-title: Putting a spin on the dorsal-ventral divide of the striatum publication-title: Trends Neurosci – volume: 23 start-page: 557 year: 1993 end-page: 564 ident: bib102 article-title: Noradrenergic modulation of cognitive function: Clinical implications of anatomical, electrophysiological and behavioural studies in animal models [editorial] publication-title: Psychol Med – year: 2001 ident: bib19 article-title: Pharmacokinetic and Pharmacodynamic Properties of Methylphenidate in Humans – volume: 100 start-page: 96 year: 2005 end-page: 106 ident: bib31 article-title: Non-medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey publication-title: Addiction – volume: 31 start-page: 2332 year: 2006 end-page: 2340 ident: bib52 article-title: Neural substrates of psychostimulant-induced arousal publication-title: Neuropsychopharmacology – volume: 24 start-page: 9914 year: 2004 end-page: 9920 ident: bib57 article-title: Phasic activation of monkey locus ceruleus neurons by simple decisions in a forced-choice task publication-title: J Neurosci – volume: 89 start-page: 340 year: 1986 end-page: 346 ident: bib49 article-title: Anatomical disassociation of amphetamine's rewarding and aversive effects: an intracranial microinjection study publication-title: Psychopharmacology (Berl) – volume: 452 start-page: 674 year: 2008 end-page: 675 ident: bib32 article-title: Poll results: Look who's doping publication-title: Nature – volume: 15 start-page: 1308 year: 1995 end-page: 1317 ident: bib34 article-title: Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine publication-title: J Neurosci – volume: 240 start-page: 345 year: 1987 end-page: 351 ident: bib62 article-title: Electrophysiological actions of cocaine on noradrenergic neurons in rat locus ceruleus publication-title: J Pharmacol Exp Ther – volume: 52 start-page: 1023 year: 1993 end-page: 1029 ident: bib75 article-title: Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes publication-title: Life Sci – volume: 173 start-page: 652 year: 1971 end-page: 654 ident: bib120 article-title: Neuron activity related to short-term memory publication-title: Science – volume: 24 start-page: 10773 year: 2004 end-page: 10785 ident: bib66 article-title: The effects of tonic locus coeruleus output on sensory-evoked responses of ventral posterior medial thalamic and barrel field cortical neurons in the awake rat publication-title: J Neurosci – start-page: 31 year: 2001 end-page: 71 ident: bib8 article-title: Clinical effects of stimulant medication in ADHD publication-title: Stimulant Drugs and ADHD: Basic and Clinical Neuroscience – volume: 319 start-page: 1327 year: 2006 end-page: 1335 ident: bib64 article-title: Low-dose methylphenidate actions on tonic and phasic locus coeruleus discharge publication-title: J Pharmacol Exp Ther – volume: 114 start-page: 154 year: 2002 end-page: 158 ident: bib128 article-title: Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene publication-title: Am J Med Genet – volume: 17 start-page: i6 year: 2007 end-page: i15 ident: bib112 article-title: Catecholamine and second messenger influences on prefrontal cortical networks of “representational knowledge”: A rational bridge between genetics and the symptoms of mental illness publication-title: Cereb Cortex – volume: 32 start-page: 354 year: 1993 end-page: 360 ident: bib79 article-title: Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette syndrome publication-title: J Am Acad Child Adolesc Psychiatry – volume: 60 start-page: 1111 year: 2006 end-page: 1120 ident: bib21 article-title: Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function publication-title: Biol Psychiatry – volume: 46 start-page: 1259 year: 1999 end-page: 1265 ident: bib99 article-title: Local infusion of an alpha-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys publication-title: Biol Psychiatry – volume: 20 start-page: RC65 year: 2000 ident: bib16 article-title: Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain publication-title: J Neurosci – volume: 3 start-page: 617 year: 2002 end-page: 628 ident: bib26 article-title: Neuroscience of attention-deficit/hyperactivity disorder: The search for endophenotypes publication-title: Nat Rev Neurosci – volume: 29 start-page: 1060 year: 2008 end-page: 1069 ident: bib118 article-title: Beta2 adrenergic agonist, clenbuterol, enhances working memory performance in aging animals publication-title: Neurobiol Aging – volume: 61 start-page: 1395 year: 2007 end-page: 1401 ident: bib71 article-title: Association between response inhibition and working memory in adult ADHD: A link to right frontal cortex pathology? publication-title: Biol Psychiatry – volume: 141 start-page: 906 year: 1984 end-page: 908 ident: bib82 article-title: Desipramine in the treatment of adolescents with attention deficit disorder publication-title: Am J Psychiatry – volume: 47 start-page: 332 year: 1973 end-page: 338 ident: bib89 article-title: Structure-activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenaline and dopaminergic neurones in rat brain homogenates publication-title: Br J Pharmacol – volume: 17 start-page: 285 year: 2008 end-page: 307 ident: bib27 article-title: Neurobiology of attention deficit hyperactivity disorder publication-title: Child Adolesc Psychiatr Clin N Am – volume: 111 start-page: 883 year: 1997 end-page: 891 ident: bib100 article-title: The alpha-2A noradrenergic receptor agonist guanfacine improves visual object discrimination reversal performance in aged rhesus monkeys publication-title: Behav Neurosci – volume: 63 start-page: 462 year: 2006 end-page: 469 ident: bib132 article-title: Prediction of heterogeneity in intelligence and adult prognosis by genetic polymorphisms in the dopamine system among children with attention-deficit/hyperactivity disorder: Evidence from 2 birth cohorts publication-title: Arch Gen Psychiatry – volume: 61 start-page: 331 year: 1989 end-page: 349 ident: bib121 article-title: Mnemonic coding of visual space in the monkey's dorsolateral prefrontal cortex publication-title: J Neurophysiol – volume: 158 start-page: 1067 year: 2001 end-page: 1074 ident: bib95 article-title: A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder publication-title: Am J Psychiatry – volume: 29 start-page: 33 year: 1989 end-page: 42 ident: bib107 article-title: A neuroanatomical and biochemical basis for attention deficit disorder with hyperactivity in children: A defect in tonic adrenaline mediated inhibition of locus coeruleus stimulation publication-title: Med Hypotheses – volume: 104 start-page: 19649 year: 2007 end-page: 19654 ident: bib28 article-title: Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation publication-title: Proc Natl Acad Sci U S A – volume: 68 start-page: 2032 year: 1997 end-page: 2037 ident: bib37 article-title: Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: Comparison with amphetamine publication-title: J Neurochem – volume: 37 start-page: 933 year: 1980 end-page: 943 ident: bib14 article-title: Dextroamphetamine publication-title: Arch Gen Psychiatry – volume: 29 start-page: 4301 year: 2009 end-page: 4311 ident: bib68 article-title: Optimality and robustness of a biophysical decision-making model under norepinephrine modulation publication-title: J Neurosci – volume: 121 start-page: e73 year: 2008 end-page: e84 ident: bib96 article-title: A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder publication-title: Pediatrics – volume: 94 start-page: 577 year: 1937 end-page: 585 ident: bib7 article-title: The behavior of children receiving benzadrine publication-title: Am J Psychiatry – volume: 21 start-page: 232 year: 1985 end-page: 236 ident: bib78 article-title: New drug trials in attention deficit disorder publication-title: Psychopharmacol Bull – volume: 232 start-page: 139 year: 1985 end-page: 143 ident: bib85 article-title: Clinical Pharmacology of tomoxetine, a potential antidepressant publication-title: J Pharmacol Exp Ther – volume: 94 start-page: 507 year: 1975 end-page: 522 ident: bib48 article-title: Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum publication-title: Brain Res – volume: 306 start-page: 882 year: 2004 end-page: 884 ident: bib116 article-title: Protein kinase C overactivity impairs prefrontal cortical regulation of working memory publication-title: Science – volume: 6 start-page: S57 year: 2002 end-page: S60 ident: bib18 article-title: Responses to methylphenidate in attention-deficit/hyperactivity disorder and normal children: Update 2002 publication-title: J Atten Disord – volume: 222 start-page: 61 year: 1982 end-page: 65 ident: bib81 article-title: A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain publication-title: J Pharmacol Exp Ther – volume: 123 start-page: 165 year: 2001 end-page: 183 ident: bib43 article-title: Neurons in rat medial prefrontal cortex show anticipatory rate changes to predictable differential rewards in a spatial memory task publication-title: Behav Brain Res – year: 2002 ident: bib60 article-title: Effects of Tonic Versus Phasic Activation of the Locus Coeruleus on Thalamic and Cortical Neuronal Responsiveness to Afferent Pathway Stimulation – volume: 53 start-page: 448 year: 1996 end-page: 455 ident: bib114 article-title: The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function publication-title: Arch Gen Psychiatry – volume: 32 start-page: 419 year: 1993 end-page: 428 ident: bib63 article-title: Cocaine effects on brain noradrenergic neurons of anesthetized and unanesthetized rats publication-title: Neuropharmacology – volume: 35 start-page: 27 year: 1989 end-page: 39 ident: bib51 article-title: Amphetamine microinjections into distinct striatal subregions cause dissociable effects on motor and ingestive behavior publication-title: Behav Brain Res – volume: 17 start-page: 692 year: 2007 end-page: 697 ident: bib44 article-title: Integrating hippocampus and striatum in decision-making publication-title: Curr Opin Neurobiol – volume: 4 start-page: 192 year: 1999 end-page: 196 ident: bib127 article-title: Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children publication-title: Mol Psychiatry – volume: 11 start-page: 164 year: 1992 end-page: 169 ident: bib33 article-title: Regional norepinephrine response to amphetamine using dialysis: Comparison with caudate dopamine publication-title: Synapse – volume: 123 start-page: 1273 year: 2009 end-page: 1279 ident: bib10 article-title: Positive association between attention-deficit/ hyperactivity disorder medication use and academic achievement during elementary school publication-title: Pediatrics – volume: 13 start-page: 247 year: 1975 end-page: 262 ident: bib1 article-title: Behavioral and neurochemical correlates of repeated d-amphetamine administration publication-title: Adv Biochem Psychopharmacol – volume: 124 start-page: 875 year: 2009 end-page: 880 ident: bib30 article-title: Adolescent prescription ADHD medication abuse is rising along with prescriptions for these medications publication-title: Pediatrics – volume: vol 3 year: 2009 ident: bib72 publication-title: Imaging Cognitive Deficits in Drug Abuse – volume: 24 start-page: 617 year: 1985 end-page: 629 ident: bib93 article-title: Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutic trial publication-title: J Am Acad Child Psychiatry – volume: 1 start-page: 2 year: 2005 ident: bib5 article-title: Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in attention deficit hyperactivity disorder publication-title: Behav Brain Funct – volume: 95 start-page: 14494 year: 1998 end-page: 14499 ident: bib15 article-title: Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study publication-title: Proc Natl Acad Sci U S A – volume: 28 start-page: 777 year: 1989 end-page: 784 ident: bib76 article-title: A double-blind placebo controlled study of desipramine in the treatment of ADD: I publication-title: J Am Acad Child Adolesc Psychiatry – volume: 28 start-page: 574 year: 2005 end-page: 582 ident: bib70 article-title: Network reset: A simplified overarching theory of locus coeruleus noradrenaline function publication-title: Trends Neurosci – volume: 129 start-page: 397 year: 2007 end-page: 410 ident: bib103 article-title: Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex publication-title: Cell – volume: 139 start-page: 23 year: 2006 end-page: 38 ident: bib113 article-title: Working memory as an emergent property of the mind and brain publication-title: Neuroscience – start-page: 303 year: 2001 end-page: 331 ident: bib17 article-title: Comparative psycholpharmacology of methylphenidate and related drugs in human volunteers, patients with ADHD, and experimental animals publication-title: Stimulant Drugs and ADHD: Basic and Clinical Neuroscience – volume: 136 start-page: 8 year: 1998 end-page: 14 ident: bib98 article-title: The alpha-2a noradrenergic agonist, guanfacine, improves delayed response performance in young adult rhesus monkeys publication-title: Psychopharmacology (Berl) – volume: 94 start-page: 469 year: 1987 end-page: 492 ident: bib50 article-title: A psychomotor stimulant theory of addiction publication-title: Psychol Rev – volume: 57 start-page: 1377 year: 2005 end-page: 1384 ident: bib58 article-title: Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions publication-title: Biol Psychiatry – volume: 321 start-page: 325 year: 1992 end-page: 335 ident: bib122 article-title: Light and electron microscopic characterization of dopamine-immunoreactive axons in human cerebral cortex publication-title: J Comp Neurol – volume: 62 start-page: 977 year: 2007 end-page: 984 ident: bib86 article-title: Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder publication-title: Biol Psychiatry – volume: 31 start-page: 2376 year: 2006 end-page: 2383 ident: bib25 article-title: Stimulants: Therapeutic actions in ADHD publication-title: Neuropsychopharmacology – volume: 64 start-page: 137 year: 2010 end-page: 159 ident: bib65 article-title: Understanding wiring and volume transmission publication-title: Brain Res Rev – volume: 52 start-page: 1023 year: 1993 ident: 10.1016/j.biopsych.2010.06.023_bib75 article-title: Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes publication-title: Life Sci doi: 10.1016/0024-3205(93)90194-8 – volume: 121 start-page: e73 year: 2008 ident: 10.1016/j.biopsych.2010.06.023_bib96 article-title: A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder publication-title: Pediatrics doi: 10.1542/peds.2006-3695 – volume: 68 start-page: 2032 year: 1997 ident: 10.1016/j.biopsych.2010.06.023_bib37 article-title: Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: Comparison with amphetamine publication-title: J Neurochem doi: 10.1046/j.1471-4159.1997.68052032.x – volume: 18 start-page: 211 year: 1997 ident: 10.1016/j.biopsych.2010.06.023_bib92 article-title: Gene targeting—homing in on alpha 2-adrenoceptor-subtype function publication-title: Trends Pharmacol Sci doi: 10.1016/S0165-6147(97)01063-8 – volume: 129 start-page: 397 year: 2007 ident: 10.1016/j.biopsych.2010.06.023_bib103 article-title: Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex publication-title: Cell doi: 10.1016/j.cell.2007.03.015 – volume: 134B start-page: 67 year: 2005 ident: 10.1016/j.biopsych.2010.06.023_bib126 article-title: Support for association between ADHD and two candidate genes: NET1 and DRD1 publication-title: Am J Med Genet B Neuropsychiatr Genet doi: 10.1002/ajmg.b.30142 – start-page: 81 year: 1994 ident: 10.1016/j.biopsych.2010.06.023_bib35 article-title: Neurochemistry of amphetamine – volume: 28 start-page: 574 year: 2005 ident: 10.1016/j.biopsych.2010.06.023_bib70 article-title: Network reset: A simplified overarching theory of locus coeruleus noradrenaline function publication-title: Trends Neurosci doi: 10.1016/j.tins.2005.09.002 – volume: 62 start-page: 977 year: 2007 ident: 10.1016/j.biopsych.2010.06.023_bib86 article-title: Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2007.03.003 – volume: 21 start-page: 144 year: 1985 ident: 10.1016/j.biopsych.2010.06.023_bib77 article-title: Desipramine in the treatment of attention deficit disorder in adolescents publication-title: Psychopharmacol Bull – volume: 20 start-page: 460 year: 1999 ident: 10.1016/j.biopsych.2010.06.023_bib97 article-title: Guanfacine, but not clonidine, improves planning and working memory performance in humans publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(98)00127-4 – volume: 96 start-page: 622 year: 2006 ident: 10.1016/j.biopsych.2010.06.023_bib39 article-title: Methylphenidate enhances noradrenergic transmission and suppresses mid- and long-latency sensory responses in the primary somatosensory cortex of awake rats publication-title: J Neurophysiol doi: 10.1152/jn.01310.2005 – volume: 23 start-page: 557 year: 1993 ident: 10.1016/j.biopsych.2010.06.023_bib102 article-title: Noradrenergic modulation of cognitive function: Clinical implications of anatomical, electrophysiological and behavioural studies in animal models [editorial] publication-title: Psychol Med doi: 10.1017/S0033291700025332 – volume: 137 start-page: 1039 year: 2006 ident: 10.1016/j.biopsych.2010.06.023_bib123 article-title: Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability publication-title: Neuroscience doi: 10.1016/j.neuroscience.2005.09.031 – volume: 4 start-page: 192 year: 1999 ident: 10.1016/j.biopsych.2010.06.023_bib127 article-title: Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4000510 – volume: 29 start-page: 33 year: 1989 ident: 10.1016/j.biopsych.2010.06.023_bib107 article-title: A neuroanatomical and biochemical basis for attention deficit disorder with hyperactivity in children: A defect in tonic adrenaline mediated inhibition of locus coeruleus stimulation publication-title: Med Hypotheses doi: 10.1016/0306-9877(89)90164-3 – volume: 1 start-page: 2 year: 2005 ident: 10.1016/j.biopsych.2010.06.023_bib5 article-title: Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in attention deficit hyperactivity disorder publication-title: Behav Brain Funct doi: 10.1186/1744-9081-1-2 – volume: 17 start-page: 285 year: 2008 ident: 10.1016/j.biopsych.2010.06.023_bib27 article-title: Neurobiology of attention deficit hyperactivity disorder publication-title: Child Adolesc Psychiatr Clin N Am doi: 10.1016/j.chc.2007.11.012 – volume: 17 start-page: 692 year: 2007 ident: 10.1016/j.biopsych.2010.06.023_bib44 article-title: Integrating hippocampus and striatum in decision-making publication-title: Curr Opin Neurobiol doi: 10.1016/j.conb.2008.01.003 – volume: 64 start-page: 626 year: 2008 ident: 10.1016/j.biopsych.2010.06.023_bib6 article-title: Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2008.04.037 – volume: 20 start-page: RC65 year: 2000 ident: 10.1016/j.biopsych.2010.06.023_bib16 article-title: Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain publication-title: J Neurosci doi: 10.1523/JNEUROSCI.20-06-j0004.2000 – volume: 452 start-page: 674 year: 2008 ident: 10.1016/j.biopsych.2010.06.023_bib32 article-title: Poll results: Look who's doping publication-title: Nature doi: 10.1038/452674a – volume: 94 start-page: 577 year: 1937 ident: 10.1016/j.biopsych.2010.06.023_bib7 article-title: The behavior of children receiving benzadrine publication-title: Am J Psychiatry doi: 10.1176/ajp.94.3.577 – volume: 46 start-page: 1259 year: 1999 ident: 10.1016/j.biopsych.2010.06.023_bib99 article-title: Local infusion of an alpha-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(99)00139-0 – year: 2002 ident: 10.1016/j.biopsych.2010.06.023_bib60 – volume: 6 start-page: S57 year: 2002 ident: 10.1016/j.biopsych.2010.06.023_bib18 article-title: Responses to methylphenidate in attention-deficit/hyperactivity disorder and normal children: Update 2002 publication-title: J Atten Disord doi: 10.1177/070674370200601S07 – volume: 37 start-page: 933 year: 1980 ident: 10.1016/j.biopsych.2010.06.023_bib14 article-title: Dextroamphetamine publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.1980.01780210091010 – volume: 306 start-page: 882 year: 2004 ident: 10.1016/j.biopsych.2010.06.023_bib116 article-title: Protein kinase C overactivity impairs prefrontal cortical regulation of working memory publication-title: Science doi: 10.1126/science.1100021 – volume: 321 start-page: 325 year: 1992 ident: 10.1016/j.biopsych.2010.06.023_bib122 article-title: Light and electron microscopic characterization of dopamine-immunoreactive axons in human cerebral cortex publication-title: J Comp Neurol doi: 10.1002/cne.903210302 – volume: 42 start-page: 840 year: 1985 ident: 10.1016/j.biopsych.2010.06.023_bib11 article-title: Stimulant therapy of “adult hyperactivity” publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.1985.01790310108018 – volume: 29 start-page: 1060 year: 2008 ident: 10.1016/j.biopsych.2010.06.023_bib118 article-title: Beta2 adrenergic agonist, clenbuterol, enhances working memory performance in aging animals publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2007.02.003 – volume: 100 start-page: 96 year: 2005 ident: 10.1016/j.biopsych.2010.06.023_bib31 article-title: Non-medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey publication-title: Addiction doi: 10.1111/j.1360-0443.2005.00944.x – volume: 57 start-page: 1377 year: 2005 ident: 10.1016/j.biopsych.2010.06.023_bib58 article-title: Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2004.08.019 – volume: 32 start-page: 354 year: 1993 ident: 10.1016/j.biopsych.2010.06.023_bib79 article-title: Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette syndrome publication-title: J Am Acad Child Adolesc Psychiatry doi: 10.1097/00004583-199303000-00017 – volume: 47 start-page: 332 year: 1973 ident: 10.1016/j.biopsych.2010.06.023_bib89 article-title: Structure-activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenaline and dopaminergic neurones in rat brain homogenates publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.1973.tb08331.x – volume: 61 start-page: 1395 year: 2007 ident: 10.1016/j.biopsych.2010.06.023_bib71 article-title: Association between response inhibition and working memory in adult ADHD: A link to right frontal cortex pathology? publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.07.020 – volume: 240 start-page: 345 year: 1987 ident: 10.1016/j.biopsych.2010.06.023_bib62 article-title: Electrophysiological actions of cocaine on noradrenergic neurons in rat locus ceruleus publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(25)22757-4 – volume: 1 start-page: 449 year: 1992 ident: 10.1016/j.biopsych.2010.06.023_bib73 article-title: Nonstimulant drugs in the treatment of attention-deficit hyperactivity disorder publication-title: Child Adolesc Psychiatr Clin N Am doi: 10.1016/S1056-4993(18)30597-2 – volume: 202 start-page: 505 year: 2009 ident: 10.1016/j.biopsych.2010.06.023_bib87 article-title: Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-008-1250-4 – volume: 39 start-page: 337 year: 1992 ident: 10.1016/j.biopsych.2010.06.023_bib104 article-title: The mechanism of action of drugs used to treat attention-deficit hyperactivity disorder: Focus on catecholamine receptor pharmacology publication-title: Adv Pediatr doi: 10.1016/S0065-3101(24)00289-5 – volume: 61 start-page: 331 year: 1989 ident: 10.1016/j.biopsych.2010.06.023_bib121 article-title: Mnemonic coding of visual space in the monkey's dorsolateral prefrontal cortex publication-title: J Neurophysiol doi: 10.1152/jn.1989.61.2.331 – volume: 165 start-page: 721 year: 2008 ident: 10.1016/j.biopsych.2010.06.023_bib13 article-title: Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: Acute comparison and differential response publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2007.05091676 – volume: 7 start-page: 143 year: 1987 ident: 10.1016/j.biopsych.2010.06.023_bib125 article-title: Mianserin pharmacokinetics and behavior in hyperkinetic children publication-title: J Clin Psychopharmacol doi: 10.1097/00004714-198706000-00004 – volume: 13 start-page: 247 year: 1975 ident: 10.1016/j.biopsych.2010.06.023_bib1 article-title: Behavioral and neurochemical correlates of repeated d-amphetamine administration publication-title: Adv Biochem Psychopharmacol – volume: 296 start-page: 876 year: 2001 ident: 10.1016/j.biopsych.2010.06.023_bib38 article-title: Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: Relative roles of dopamine and norepinephrine publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(24)38829-9 – volume: 139 start-page: 23 year: 2006 ident: 10.1016/j.biopsych.2010.06.023_bib113 article-title: Working memory as an emergent property of the mind and brain publication-title: Neuroscience doi: 10.1016/j.neuroscience.2005.06.005 – volume: 24 start-page: 9914 year: 2004 ident: 10.1016/j.biopsych.2010.06.023_bib57 article-title: Phasic activation of monkey locus ceruleus neurons by simple decisions in a forced-choice task publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2446-04.2004 – volume: 42 start-page: 33 year: 2003 ident: 10.1016/j.biopsych.2010.06.023_bib56 article-title: The locus coeruleus-noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes publication-title: Brain Res Brain Res Rev doi: 10.1016/S0165-0173(03)00143-7 – volume: 94 start-page: 507 year: 1975 ident: 10.1016/j.biopsych.2010.06.023_bib48 article-title: Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum publication-title: Brain Res doi: 10.1016/0006-8993(75)90233-4 – volume: 36 start-page: 1204 year: 1997 ident: 10.1016/j.biopsych.2010.06.023_bib24 article-title: Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder publication-title: J Am Acad Child Adolesc Psychiatry doi: 10.1097/00004583-199709000-00012 – volume: 94 start-page: 469 year: 1987 ident: 10.1016/j.biopsych.2010.06.023_bib50 article-title: A psychomotor stimulant theory of addiction publication-title: Psychol Rev doi: 10.1037/0033-295X.94.4.469 – volume: 34 start-page: 50 year: 1995 ident: 10.1016/j.biopsych.2010.06.023_bib94 article-title: An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder publication-title: J Am Acad Child Adolesc Psychiatry doi: 10.1097/00004583-199501000-00013 – volume: 3 start-page: 617 year: 2002 ident: 10.1016/j.biopsych.2010.06.023_bib26 article-title: Neuroscience of attention-deficit/hyperactivity disorder: The search for endophenotypes publication-title: Nat Rev Neurosci doi: 10.1038/nrn896 – volume: 43 start-page: 820 year: 2004 ident: 10.1016/j.biopsych.2010.06.023_bib12 article-title: Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment publication-title: J Am Acad Child Adolesc Psychiatry doi: 10.1097/01.chi.0000128797.91601.1a – volume: 111 start-page: 883 year: 1997 ident: 10.1016/j.biopsych.2010.06.023_bib100 article-title: The alpha-2A noradrenergic receptor agonist guanfacine improves visual object discrimination reversal performance in aged rhesus monkeys publication-title: Behav Neurosci doi: 10.1037/0735-7044.111.5.883 – volume: 95 start-page: 14494 year: 1998 ident: 10.1016/j.biopsych.2010.06.023_bib15 article-title: Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.95.24.14494 – volume: 43 start-page: 181 year: 2002 ident: 10.1016/j.biopsych.2010.06.023_bib47 article-title: Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications publication-title: Synapse doi: 10.1002/syn.10038 – volume: 466 start-page: 478 year: 2003 ident: 10.1016/j.biopsych.2010.06.023_bib67 article-title: Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals publication-title: J Comp Neurol doi: 10.1002/cne.10898 – volume: 58 start-page: 1 year: 2008 ident: 10.1016/j.biopsych.2010.06.023_bib53 article-title: Noradrenergic modulation of arousal publication-title: Brain Res Rev doi: 10.1016/j.brainresrev.2007.10.013 – volume: 26 start-page: 676 year: 1987 ident: 10.1016/j.biopsych.2010.06.023_bib106 article-title: Neurobiology of attention deficit disorder with hyperactivity: Where have we come in 50 years? publication-title: J Am Acad Child Adolesc Psychiatry doi: 10.1097/00004583-198709000-00011 – volume: 35 start-page: 27 year: 1989 ident: 10.1016/j.biopsych.2010.06.023_bib51 article-title: Amphetamine microinjections into distinct striatal subregions cause dissociable effects on motor and ingestive behavior publication-title: Behav Brain Res doi: 10.1016/S0166-4328(89)80005-1 – volume: 123 start-page: 1273 year: 2009 ident: 10.1016/j.biopsych.2010.06.023_bib10 article-title: Positive association between attention-deficit/ hyperactivity disorder medication use and academic achievement during elementary school publication-title: Pediatrics doi: 10.1542/peds.2008-1597 – volume: 46 start-page: 140 year: 2002 ident: 10.1016/j.biopsych.2010.06.023_bib4 article-title: Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex publication-title: Synapse doi: 10.1002/syn.10131 – volume: 21 start-page: 232 year: 1985 ident: 10.1016/j.biopsych.2010.06.023_bib78 article-title: New drug trials in attention deficit disorder publication-title: Psychopharmacol Bull – volume: 11 start-page: 164 year: 1992 ident: 10.1016/j.biopsych.2010.06.023_bib33 article-title: Regional norepinephrine response to amphetamine using dialysis: Comparison with caudate dopamine publication-title: Synapse doi: 10.1002/syn.890110210 – volume: 319 start-page: 1327 year: 2006 ident: 10.1016/j.biopsych.2010.06.023_bib64 article-title: Low-dose methylphenidate actions on tonic and phasic locus coeruleus discharge publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.106.110015 – volume: 9 start-page: 329 year: 1983 ident: 10.1016/j.biopsych.2010.06.023_bib105 article-title: An open trial of pargyline in the treatment of attention deficit disorder, residual type publication-title: Psychiatry Res doi: 10.1016/0165-1781(83)90006-9 – volume: 23 start-page: 240 year: 2000 ident: 10.1016/j.biopsych.2010.06.023_bib101 article-title: The alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory task publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(00)00111-1 – volume: 57 start-page: 1273 year: 2005 ident: 10.1016/j.biopsych.2010.06.023_bib29 article-title: Functional neuroimaging of attention-deficit/hyperactivity disorder: A review and suggested future directions publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2005.01.034 – volume: 64 start-page: 137 year: 2010 ident: 10.1016/j.biopsych.2010.06.023_bib65 article-title: Understanding wiring and volume transmission publication-title: Brain Res Rev doi: 10.1016/j.brainresrev.2010.03.003 – volume: 42 start-page: 838 year: 2006 ident: 10.1016/j.biopsych.2010.06.023_bib129 article-title: The cognitive genetics of attention deficit hyperactivity disorder (ADHD): Sustained attention as a candidate phenotype publication-title: Cortex doi: 10.1016/S0010-9452(08)70426-X – volume: 141 start-page: 906 year: 1984 ident: 10.1016/j.biopsych.2010.06.023_bib82 article-title: Desipramine in the treatment of adolescents with attention deficit disorder publication-title: Am J Psychiatry doi: 10.1176/ajp.141.7.906 – volume: 126 start-page: 183 year: 2000 ident: 10.1016/j.biopsych.2010.06.023_bib91 article-title: Stress impairs prefrontal cortical function in rats and monkeys: Role of dopamine D1 and norepinephrine alpha-1 receptor mechanisms publication-title: Prog Brain Res doi: 10.1016/S0079-6123(00)26014-7 – volume: 41 start-page: 133 year: 1977 ident: 10.1016/j.biopsych.2010.06.023_bib90 article-title: Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(77)90202-3 – volume: 29 start-page: 4301 year: 2009 ident: 10.1016/j.biopsych.2010.06.023_bib68 article-title: Optimality and robustness of a biophysical decision-making model under norepinephrine modulation publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5024-08.2009 – volume: 15 start-page: 1308 year: 1995 ident: 10.1016/j.biopsych.2010.06.023_bib34 article-title: Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine publication-title: J Neurosci doi: 10.1523/JNEUROSCI.15-02-01308.1995 – volume: 158 start-page: 1067 year: 2001 ident: 10.1016/j.biopsych.2010.06.023_bib95 article-title: A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.158.7.1067 – start-page: 31 year: 2001 ident: 10.1016/j.biopsych.2010.06.023_bib8 article-title: Clinical effects of stimulant medication in ADHD – volume: 22 start-page: 7264 year: 2002 ident: 10.1016/j.biopsych.2010.06.023_bib20 article-title: Exposure of adolescent rats to oral methylphenidate: Preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine publication-title: J Neurosci doi: 10.1523/JNEUROSCI.22-16-07264.2002 – volume: 17 start-page: i6 issue: suppl 1 year: 2007 ident: 10.1016/j.biopsych.2010.06.023_bib112 article-title: Catecholamine and second messenger influences on prefrontal cortical networks of “representational knowledge”: A rational bridge between genetics and the symptoms of mental illness publication-title: Cereb Cortex doi: 10.1093/cercor/bhm033 – volume: 123 start-page: 165 year: 2001 ident: 10.1016/j.biopsych.2010.06.023_bib43 article-title: Neurons in rat medial prefrontal cortex show anticipatory rate changes to predictable differential rewards in a spatial memory task publication-title: Behav Brain Res doi: 10.1016/S0166-4328(01)00204-2 – volume: 147B start-page: 485 year: 2008 ident: 10.1016/j.biopsych.2010.06.023_bib130 article-title: The -1021 C/T DBH polymorphism is associated with neuropsychological performance among children and adolescents with ADHD publication-title: Am J Med Genet B Neuropsychiatr Genet doi: 10.1002/ajmg.b.30636 – volume: 24 start-page: 5292 year: 2004 ident: 10.1016/j.biopsych.2010.06.023_bib110 article-title: Microdomains for dopamine volume neurotransmission in primate prefrontal cortex publication-title: J Neurosci doi: 10.1523/JNEUROSCI.0195-04.2004 – volume: 31 start-page: 2376 year: 2006 ident: 10.1016/j.biopsych.2010.06.023_bib25 article-title: Stimulants: Therapeutic actions in ADHD publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301164 – volume: 104 start-page: 19649 year: 2007 ident: 10.1016/j.biopsych.2010.06.023_bib28 article-title: Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0707741104 – volume: 58 start-page: 894 year: 2005 ident: 10.1016/j.biopsych.2010.06.023_bib117 article-title: The beta-1 adrenergic antagonist, betaxolol, improves working memory performance in rats and monkeys publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2005.05.022 – volume: 114 start-page: 154 year: 2002 ident: 10.1016/j.biopsych.2010.06.023_bib128 article-title: Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene publication-title: Am J Med Genet doi: 10.1002/ajmg.10194 – volume: 126 start-page: 51 year: 2009 ident: 10.1016/j.biopsych.2010.06.023_bib131 article-title: Candidate gene studies of ADHD: A meta-analytic review publication-title: Hum Genet doi: 10.1007/s00439-009-0694-x – volume: 27 start-page: 468 year: 2004 ident: 10.1016/j.biopsych.2010.06.023_bib45 article-title: Putting a spin on the dorsal-ventral divide of the striatum publication-title: Trends Neurosci doi: 10.1016/j.tins.2004.06.006 – volume: 32 start-page: 419 year: 1993 ident: 10.1016/j.biopsych.2010.06.023_bib63 article-title: Cocaine effects on brain noradrenergic neurons of anesthetized and unanesthetized rats publication-title: Neuropharmacology doi: 10.1016/0028-3908(93)90165-Y – volume: 60 start-page: 1111 year: 2006 ident: 10.1016/j.biopsych.2010.06.023_bib21 article-title: Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.04.022 – year: 2008 ident: 10.1016/j.biopsych.2010.06.023_bib59 article-title: The locus coeruleus-noradrenergic system and stress: Implications for post-traumatic stress disorder (PTSD) – volume: 46 start-page: 1266 year: 1999 ident: 10.1016/j.biopsych.2010.06.023_bib115 article-title: A role for norepinephrine in stress-induced cognitive deficits: Alpha-1-adrenoceptor mediation in the prefrontal cortex publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(99)00138-9 – volume: 63 start-page: 462 year: 2006 ident: 10.1016/j.biopsych.2010.06.023_bib132 article-title: Prediction of heterogeneity in intelligence and adult prognosis by genetic polymorphisms in the dopamine system among children with attention-deficit/hyperactivity disorder: Evidence from 2 birth cohorts publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.63.4.462 – year: 1985 ident: 10.1016/j.biopsych.2010.06.023_bib74 article-title: Antidepressant agents – volume: 21 start-page: 161 year: 1999 ident: 10.1016/j.biopsych.2010.06.023_bib108 article-title: Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(98)00112-2 – volume: 155 start-page: 693 year: 1998 ident: 10.1016/j.biopsych.2010.06.023_bib83 article-title: Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder publication-title: Am J Psychiatry doi: 10.1176/ajp.155.5.693 – volume: 94 start-page: 127 year: 1998 ident: 10.1016/j.biopsych.2010.06.023_bib23 article-title: Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration publication-title: Behav Brain Res doi: 10.1016/S0166-4328(97)00175-7 – volume: 89 start-page: 340 year: 1986 ident: 10.1016/j.biopsych.2010.06.023_bib49 article-title: Anatomical disassociation of amphetamine's rewarding and aversive effects: an intracranial microinjection study publication-title: Psychopharmacology (Berl) doi: 10.1007/BF00174372 – volume: 31 start-page: 2332 year: 2006 ident: 10.1016/j.biopsych.2010.06.023_bib52 article-title: Neural substrates of psychostimulant-induced arousal publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301159 – volume: 53 start-page: 448 year: 1996 ident: 10.1016/j.biopsych.2010.06.023_bib114 article-title: The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.1996.01830050084013 – ident: 10.1016/j.biopsych.2010.06.023_bib124 doi: 10.1016/j.jaac.2010.06.015 – volume: 232 start-page: 139 year: 1985 ident: 10.1016/j.biopsych.2010.06.023_bib85 article-title: Clinical Pharmacology of tomoxetine, a potential antidepressant publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(25)20085-4 – volume: 28 start-page: 777 year: 1989 ident: 10.1016/j.biopsych.2010.06.023_bib76 article-title: A double-blind placebo controlled study of desipramine in the treatment of ADD: I publication-title: J Am Acad Child Adolesc Psychiatry doi: 10.1097/00004583-198909000-00022 – start-page: 77 year: 2001 ident: 10.1016/j.biopsych.2010.06.023_bib109 article-title: The catecholamine innervation of primate cerebral cortex – volume: 55 start-page: 1067 year: 1990 ident: 10.1016/j.biopsych.2010.06.023_bib40 article-title: Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: Evidence that dopamine is taken up in vivo by noradrenergic terminals publication-title: J Neurochem doi: 10.1111/j.1471-4159.1990.tb04599.x – volume: 8 start-page: 153 year: 1984 ident: 10.1016/j.biopsych.2010.06.023_bib2 article-title: Critical issues in assessing the behavioral effects of amphetamine publication-title: Neurosci Biobehav Rev doi: 10.1016/0149-7634(84)90030-7 – year: 2008 ident: 10.1016/j.biopsych.2010.06.023_bib22 – volume: 124 start-page: 875 year: 2009 ident: 10.1016/j.biopsych.2010.06.023_bib30 article-title: Adolescent prescription ADHD medication abuse is rising along with prescriptions for these medications publication-title: Pediatrics doi: 10.1542/peds.2008-0931 – volume: 222 start-page: 61 year: 1982 ident: 10.1016/j.biopsych.2010.06.023_bib81 article-title: A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(25)33153-8 – volume: 117 start-page: 340 year: 1995 ident: 10.1016/j.biopsych.2010.06.023_bib3 article-title: Behavioral vigilance in rats: Task validation and effects of age, amphetamine, and benzodiazepine receptor ligands publication-title: Psychopharmacology (Berl) doi: 10.1007/BF02246109 – volume: 18 start-page: 2697 year: 1998 ident: 10.1016/j.biopsych.2010.06.023_bib41 article-title: Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter publication-title: J Neurosci doi: 10.1523/JNEUROSCI.18-07-02697.1998 – volume: 28 start-page: 403 year: 2005 ident: 10.1016/j.biopsych.2010.06.023_bib69 article-title: An integrative theory of locus coeruleus-norepinephrine function: Adaptive gain and optimal performance publication-title: Annu Rev Neurosci doi: 10.1146/annurev.neuro.28.061604.135709 – volume: vol 3 year: 2009 ident: 10.1016/j.biopsych.2010.06.023_bib72 – volume: 64 start-page: 3 issue: suppl 11 year: 2003 ident: 10.1016/j.biopsych.2010.06.023_bib54 article-title: Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: Findings from a longitudinal follow-up of youths with and without ADHD publication-title: J Clin Psychiatry – volume: 173 start-page: 652 year: 1971 ident: 10.1016/j.biopsych.2010.06.023_bib120 article-title: Neuron activity related to short-term memory publication-title: Science doi: 10.1126/science.173.3997.652 – year: 2001 ident: 10.1016/j.biopsych.2010.06.023_bib19 – volume: 10 start-page: 193 year: 2000 ident: 10.1016/j.biopsych.2010.06.023_bib80 article-title: A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder publication-title: J Child Adolesc Psychopharmacol doi: 10.1089/10445460050167304 – volume: 14 start-page: 488 year: 2004 ident: 10.1016/j.biopsych.2010.06.023_bib61 article-title: A matter of focus: Monoaminergic modulation of stimulus coding in mammalian sensory networks publication-title: Curr Opin Neurobiol doi: 10.1016/j.conb.2004.06.007 – volume: 654 start-page: 53 year: 1994 ident: 10.1016/j.biopsych.2010.06.023_bib36 article-title: Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment publication-title: Brain Res doi: 10.1016/0006-8993(94)91570-9 – volume: 492 start-page: 145 year: 2005 ident: 10.1016/j.biopsych.2010.06.023_bib46 article-title: Prefrontal cortex in the rat: Projections to subcortical autonomic, motor, and limbic centers publication-title: J Comp Neurol doi: 10.1002/cne.20738 – volume: 111 start-page: 179 year: 2003 ident: 10.1016/j.biopsych.2010.06.023_bib55 article-title: Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? publication-title: Pediatrics doi: 10.1542/peds.111.1.179 – volume: 24 start-page: 10773 year: 2004 ident: 10.1016/j.biopsych.2010.06.023_bib66 article-title: The effects of tonic locus coeruleus output on sensory-evoked responses of ventral posterior medial thalamic and barrel field cortical neurons in the awake rat publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1573-04.2004 – start-page: 303 year: 2001 ident: 10.1016/j.biopsych.2010.06.023_bib17 article-title: Comparative psycholpharmacology of methylphenidate and related drugs in human volunteers, patients with ADHD, and experimental animals – volume: 28 start-page: 771 year: 2004 ident: 10.1016/j.biopsych.2010.06.023_bib42 article-title: Prefrontal executive and cognitive functions in rodents: Neural and neurochemical substrates publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2004.09.006 – volume: 136 start-page: 8 year: 1998 ident: 10.1016/j.biopsych.2010.06.023_bib98 article-title: The alpha-2a noradrenergic agonist, guanfacine, improves delayed response performance in young adult rhesus monkeys publication-title: Psychopharmacology (Berl) doi: 10.1007/s002130050533 – volume: 43 start-page: 812 year: 2004 ident: 10.1016/j.biopsych.2010.06.023_bib9 article-title: Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment publication-title: J Am Acad Child Adolesc Psychiatry doi: 10.1097/01.chi.0000128796.84202.eb – volume: 10 start-page: 376 year: 2007 ident: 10.1016/j.biopsych.2010.06.023_bib119 article-title: Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory publication-title: Nat Neurosci doi: 10.1038/nn1846 – volume: 350 start-page: 610 year: 1991 ident: 10.1016/j.biopsych.2010.06.023_bib111 article-title: Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine publication-title: Nature doi: 10.1038/350610a0 – volume: 24 start-page: 617 year: 1985 ident: 10.1016/j.biopsych.2010.06.023_bib93 article-title: Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutic trial publication-title: J Am Acad Child Psychiatry doi: 10.1016/S0002-7138(09)60065-0 – volume: 53 start-page: 112 year: 2003 ident: 10.1016/j.biopsych.2010.06.023_bib84 article-title: Atomoxetine in adults with ADHD: Two randomized, placebo-controlled studies publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(02)01671-2 – volume: 27 start-page: 699 year: 2002 ident: 10.1016/j.biopsych.2010.06.023_bib88 article-title: Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit/hyperactivity disorder publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(02)00346-9 |
| SSID | ssj0007221 |
| Score | 2.3871303 |
| SecondaryResourceType | review_article |
| Snippet | Psychostimulants exert behavioral-calming and cognition-enhancing actions in the treatment of attention-deficit/hyperactivity disorder (ADHD). Contrary to... Psychostimulants exert behavioral-calming and cognition-enhancing actions in the treatment of attention deficit hyperactivity disorder (ADHD). Contrary to... |
| SourceID | pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e101 |
| SubjectTerms | ADHD Adrenergic Agonists - pharmacology Adrenergic Agonists - therapeutic use Animals Antidepressive Agents - pharmacology Antidepressive Agents - therapeutic use Attention Deficit Disorder with Hyperactivity - drug therapy Attention Deficit Disorder with Hyperactivity - physiopathology Catecholamines - metabolism Catecholamines - physiology Central Nervous System Stimulants - pharmacology Central Nervous System Stimulants - therapeutic use cognition Cognition - drug effects Cognition - physiology dopamine Humans Monoamine Oxidase Inhibitors - pharmacology Monoamine Oxidase Inhibitors - therapeutic use Neurons - physiology norepinephrine prefrontal cortex Prefrontal Cortex - drug effects Prefrontal Cortex - metabolism Prefrontal Cortex - physiopathology Psychiatry stimulants Synaptic Transmission - drug effects Synaptic Transmission - physiology |
| Title | Psychostimulants as Cognitive Enhancers: The Prefrontal Cortex, Catecholamines, and Attention-Deficit/Hyperactivity Disorder |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0006322310006785 https://www.clinicalkey.es/playcontent/1-s2.0-S0006322310006785 https://dx.doi.org/10.1016/j.biopsych.2010.06.023 https://www.ncbi.nlm.nih.gov/pubmed/20875636 https://www.proquest.com/docview/870547007 https://pubmed.ncbi.nlm.nih.gov/PMC3012746 |
| Volume | 69 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwEB1Vrfi4VLBAWQqVDxyb3cRxnKS3VWi1gFpxoFJvlrOx1a3abNVkJZCq_nZmEnvpUiEQXJOMbNnP43H85g3Ae5L1yUorAm01xwNKZIKc6zyYWZGVWRUlaXcVc3wip6fi01lytgGFz4UhWqXz_b1P77y1ezJ2ozm-ns8pxxe3V867P9TocinRXIiUUD66-0nzSDl3VfNkQF_fyxK-GJXzRUcqdhQvOQp5_LsN6mEA-iuP8t7GdPQMtl1EySZ9p5_DhqkH8KivMfl9AE8KX9JtAI-P3U36C7jtPR8u8KvlJXFhmG5Y4blE7LA-JzjcNAcMgcS-YDdJ6QDbKYid-22fFZrkX_FgfEXE-X2m64pN2rZnTwYfDClTtOMpHnO7PCwqUcG81OdLOD06_FpMA1eJIZgledYGmaFCnnjuNlZba3NRYVSCkYtItTGG52VoM_QdWuZpZUMdlaSTZ6tQVqYSWsziV7BZL2rzGljJYxliVCRL0hqkUudhXOk8znUi0FQMIfHDr2ZOppyqZVwqz0e7UH7aFE2bImIej4cwXtld90Idf7RI_ewqn4aKjlPhXvJvlqZx679RkWq4CtUDjA4hX1muwfyvWmUeggpxQxc7ujaLZaPQ5yYiRawPYadH5GoIOFUskLHELq9hdfUByYuvv6nn553MeEysBCHf_EeXd-Fp_w9eBlHyFjbbm6V5h0FcW-51q3QPtiYfP09PfgB_Q0oi |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Pb9MwFH4anWBcEBQG5acPHJc1cRwn4VaFTR1bKw6btJvlNLbWaUunJZVA4o_nvcSJViYEgmuSp1j2l8_P8efvAXwkW58kt8LTVnNcoATGS7lOvYUVSZ4UQRQ3WzGzuZyeiS_n0fkWZN1ZGJJVOu5vOb1ha3dl7HpzfLNc0hlfnF45b_5QI-VGD2Cb3KmiAWxPjo6n856QY85d4TzpUcCdg8KX-_ly1eiKncpL7vs8_N0cdT8H_VVKeWduOnwKT1xSySZtu5_BlimH8LAtM_l9CDtZV9VtCI9mbjP9OfxoyQ-_8ev1FclhmK5Y1smJ2EF5QYi4rT4xxBL7is0kswN8T0YC3W97LNPkAItr42vSzu8xXRZsUtetgNL7bMicoh5PcaXbHMWiKhWsc_t8AWeHB6fZ1HPFGLxFlCa1lxiq5YlLb2O1tTYVBSYmmLyIWBtjeJr7NkH60DKNC-vrICerPFv4sjCF0GIR7sKgXJXmFbCch9LHxEjmZDdI1c79sNBpmOpIYKgYQdR1v1o4p3IqmHGlOknapeqGTdGwKdLm8XAE4z7upvXq-GNE3I2u6k6iIncqnE7-LdJUjgIqFaiKK1_dg-kI0j5yA-l_9VbWQVAhbmhvR5dmta4U0i5iH7E-gpctIvsu4FS0QIYSm7yB1f4BchjfvFMuLxqn8ZCECUK-_o8mf4Cd6ensRJ0czY_fwOP2l7z0gugtDOrbtXmHOV2dv3ff7E-eLEzT |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Psychostimulants+as+Cognitive+Enhancers%3A+The+Prefrontal+Cortex%2C+Catecholamines%2C+and+Attention-Deficit%2FHyperactivity+Disorder&rft.jtitle=Biological+psychiatry+%281969%29&rft.au=Berridge%2C+Craig+W.&rft.au=Devilbiss%2C+David+M.&rft.date=2011-06-15&rft.issn=0006-3223&rft.volume=69&rft.issue=12&rft.spage=e101&rft.epage=e111&rft_id=info:doi/10.1016%2Fj.biopsych.2010.06.023&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_biopsych_2010_06_023 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00063223%2FS0006322311X00100%2Fcov150h.gif |